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Abstract
One purpose was to identify the need for specialized care (My Clinic) for women with a prepregnancy body mass index (BMI) of ≥ 35 kg/m2. Women receiving My Clinic care were
compared to a matched cohort control group (perinatal database, N=47). My Clinic care
significantly reduced rates of macrosomia (5% vs 28%, p=0.02) and small birth weight
babies (0% vs 6%, p=0.00) compared to perinatal database.
The second purpose was to test the efficacy of a Nutrition and Exercise Lifestyle Intervention
Program (NELIP) in this clinical setting to prevent excessive weight gain, macrosmia, small
birth weight babies and pregnancy complications. Twelve women with a BMI ≥ 35 kg/m2
were randomized between 12-20 weeks of pregnancy to Nutrition-only, Exercise-only, or full
NELIP. Exercise-only intervention reduced rate of weight gain (0.15 ± 0.13 kg/week vs 0.61
± 0.12 kg/week, p=0.01) compared to Nutrition-only. Combining a nutrition and exercise
intervention appeared difficult for this population, as 100% of the women randomized to full
NELIP did not complete the program.

Keywords
“Obesity, gestational weight gain, exercise and pregnancy, nutrition and pregnancy,
gestational diabetes mellitus, macrosomia, small birth weight”
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Chapter 1

1

Obesity

The following chapter will begin by discussing the prevalence of obesity in the nonpregnant individual. The chapter will review obesity management, psychosocial issues
associated with obesity, physical activity and obesity, barriers and challenges of obesity
and the role of health care practitioners in the treatment and prevention of obesity. The
latter half of the chapter will focus on maternal obesity and discuss what has been learned
from weight management issues in the non-pregnant obese population to assist in
preventing excessive gestational weight gain in obese pregnant women. Increased
pregnancy complications, childhood obesity risk and the risk of gestational diabetes
mellitus as a result of obesity will also be discussed. Pregnancy weight gain guidelines
will be examined, and physical activity during pregnancy will be discussed. Maternal
obesity management and intervention strategies will be evaluated while considering the
challenges and barriers to adopting a healthy lifestyle for an obese pregnant woman with
a summary of factors that may relate to successful intervention strategies.

1.1 Prevalence of Obesity
Obesity is the second highest cause of preventable disability and death in the developed
world (House of Commons Health Committee, 2004). Obesity is clinically defined by
body mass index (BMI), which is calculated by dividing weight in kilograms by height in
meters squared (kg/m2) (Gilmore, 1999). There are three classes of obesity outlined by
the World Health Organization (WHO, 1997). A BMI of 30.0 to 34.9kg/m2 constitutes
Obese Class I (high risk of developing health problems), 35.0 to 39.9kg/m2 constitutes
Class II (very high risk), and ≥40.0kg/m2 constitutes Class III (extremely high risk) (see
Table 1). The WHO estimates that 1.9 million people die annually as a result of physical
inactivity, while 2.6 million people die as a direct result of being overweight and/or obese
(Tunstall-Pedoe, 2006). The morbidity and mortality associated with obesity presents a
huge economic burden on the Canadian health care system (Plourde, 2006). Over a
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decade ago, in 2001, the cost of obesity was estimated at $4.3 billion per year (Pirkola et
al., 2010).
Table 1: Body mass index (BMI) classification related to health risks for men and
women
BMI range

Risk of developing health
problems

Underweight

<18.5

Increased

Normal weight

18.5 to 24.9

Least

Overweight

25.0 to 29.9

Increased

Obese Class I

30.0 to 34.9

High

Obese Class II

35.0 to 39.9

Very high

Obese Class III

≥40.0

Extremely high

Source: Davies et al., 2010

1.1.1

Obesity Management

The Canadian Obesity Network (2011) describes obesity as a chronic and often
progressive condition that requires realistic and sustainable treatment strategies for
successful weight and health management (Canadian Obesity Network, 2011). To best
treat obesity the ‘5 A’s of Obesity Management’ were created for the non-pregnant
population. Firstly, health care providers must ask for permission to discuss weight, as it
is a sensitive issue that may evoke feelings of embarrassment, fear, blame and stigma.
Secondly, all obesity related risks based on BMI classification and potential causes of
weight gain should be assessed. Thirdly, health care providers should advise on obesity
risks and discuss the benefits of weight loss and treatment plans. Emphasis should be
placed on improving overall health and well-being rather than weight loss. Health care
providers and patients should agree on realistic weight-loss expectations and initiate a
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SMART plan (specific, measurable, achievable, rewarding and timely goals). It is
important to help patients set weight targets based on a weight that is sustainable while
still enjoying life. Unrealistic weight-loss expectations can lead to disappointment and
non-adherence. Lastly, providers should assist in addressing barriers, and offer education,
resources, referrals and follow-up appointments as necessary. It is important to identify
the ‘root causes’ of weight gain when considering the barriers to weight management.
Weight gain may result from a reduction in metabolic rate, overeating, or reduced
physical activity. However, these factors typically stem from psychological or
socioeconomic issues (Canadian Obesity Network, 2011).

1.1.2

Psychosocial Issues of Obesity

Stress during childhood has been associated with increased risk for weight problems
during adolescence and adulthood (Johnson et al., 2002). Eating disorders, anxiety and
compulsive behaviours seen in adult obese patients are often associated with past or
ongoing abuse (whether that be physical, sexual or emotional) (Grilo et al., 2006). Van
der Waerden et al. (2013) found that exercise has both a preventative and therapeutic
impact on mental health problems that occasionally underlie an obesity diagnosis. The
study attempted to reduce stress and depressive symptoms in women with lowsocioeconomic status using a group-based program consisting of part physical exercise
and part psycho-education (Van der Waerden et al., 2013). The psycho-education
component involved a multi-component intervention developed to counter the negative
effects of stressful events, reduce depressive symptoms and improve access to
psychological resources (Van der Waerden et al., 2013). The intervention was nonstigmatizing, as it was presented and executed as a course rather than therapy. This was
important in low SES groups as they are more likely to report stigma concerns for mental
health issues, which may inhibit their use of mental health services (Grote et al., 2007).
Literature typically suggests that a population of women with low-socioeconomic status
is generally considered hard to reach for participation in prevention and research trials
(Gadalla, 2008). However, it was found that exercise alone or in combination with
psycho-education is a viable prevention option for disadvantaged women, especially
those women with low-socioeconomic status who have been found to have higher rates of
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stress, depression and anxiety (Van der Waerden et al., 2013). It is recommended that
health care professionals complete mental health screening, as deemed appropriate on
obese adults (Lau et al., 2006).
Obesity prevalence is greater in lower socioeconomic groups (Mauro et al., 2008). This
can be attributable to the greater number of fast-food restaurants in low-income
neighbourhoods, the high cost of healthy food, safety concerns that prevent walking or
outdoor activities, and greater social acceptance of excess body weight (Mauro et al.,
2008). The affordability of gym memberships, commercial weight-loss programs and
obesity medications may also be barriers for low-income individuals (Mauro et al., 2008).

1.1.3

Physical Activity and Obesity

Sedentary lifestyle contributes to the prevalence of overweight and obesity (Ball et al.,
2000; National Audit Office, 2001). Increased exercise engagement should therefore be
one tool to tackle the ‘obesity epidemic’ (Tunstall-Pedoe, 2006). Simple activities like
walking, rather than vigorous exercise or competitive sports, is one strategy that should
be targeted to obese individuals (Ball et al., 2000). The use of a pedometer as a tracking
device and feedback tool is an effective way to increase physical activity (Tudor-Locke et
al., 2002). Taking 10,000 steps per day is considered an active lifestyle; 3100-4000 steps
taken are equivalent to 30 minutes of walking at a moderate intensity (Tudor-Locke et al.,
2002). Promotion of regular physical activity will potentially deliver multiple health
benefits at a population level through reducing the health effects associated with
inactivity, overweight and obesity (Ball et al., 2000).

1.1.4

Barriers to Physical Activity in Obese Individuals

Little research has been conducted on exercise initiation and maintenance among obese
individuals (Biddle & Fox, 1998). A significant proportion (22.6%) of obese participants
report that being too fat is a barrier to increasing their level of physical activity, and many
of these respondents were women (Ball et al., 2000). Other intrapersonal barriers reported
include comorbidities (mental health, sleep, pain, cardiovascular (CV) disease, etc.), an
injury or disability, too shy or embarrassed, not athletic, being generally unmotivated and
lazy to initiate an exercise program, disproportionate focus on weight loss, and previous
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negative experiences with exercise (Ball et al., 2000; Chambliss et al., 2004; Mauro et al.,
2008). Environmental factors such as proximity to facilities, as well as personal factors
such as time constraints and children, are common barriers frequently reported by both
normal and overweight individuals (Chambliss et al., 2004). Further research is required
to consider the intrapersonal factors that reinforce the initiation and maintenance of
physical activity among the obese (Ball et al., 2000).

1.1.5

Challenges and Barriers of Obesity

One of the most successful and recent prevention interventions in public health was
promoting smoking cessation (Volkow & Wise, 2005). The obesity epidemic offers a
unique challenge, as food, unlike cigarettes, is necessary for survival. It is difficult for a
society to implement regulations that will limit easy access to food that can lead to
compulsive eating. Restricted access to high-fat high-calorie foods that are unnecessary
for the maintenance of good health is required, particularly in public places (Volkow &
Wise, 2005).
It is essential that health behaviour counseling is framed in a positive manner (emphasize
the health benefits of increased physical activity and weight loss) rather than in a negative
manner (emphasizing the detrimental effects of remaining obese) (Forman-Hoffman et
al., 2006). Some clinicians believe that having obese patients complete questionnaires
rating their readiness to change prior to the visit would be helpful (Forman-Hoffman et
al., 2006). Further research is required to determine the effectiveness of this strategy.
Whether health care providers accept obesity as a chronic disease influences the way
obese patients are counseled; 83% of clinicians who considered obesity a disease
counseled their patients in a positive context, while only 50% of clinicians who did not
consider obesity a disease counseled their patients in a positive context (FormanHoffman et al., 2006). Clinicians who believe obesity is a disease may be more
compassionate towards obese patients versus those clinicians who believe obesity is a
result of a character flaw or a lack of willpower (Forman-Hoffman et al., 2006). Research
indicates that health care providers who are most likely to counsel patients on weight
management practices initiated conversations by “medicalizing” the obesity (Kizer et al.,
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2000). In a recent report, the American Heart Association (AHA) now considers obesity a
disease (Jensen et al., 2013) and advocates weight loss in obese individuals to prevent
heart disease and stroke, America’s number one and number four killers, respectively
(Jensen et al., 2013). The health problems and risk factors of obesity that are being passed
down through the generations can no longer be ignored (Jensen et al., 2013). A
collaborative effort between the AHA, the American College of Cardiology (ACC) and
the National Heart, Lung, and Blood Institute (NHLBI) resulted in updated evidencebased guidelines designed for health care providers to help patients lose weight and keep
it off (Jensen et al., 2013).

1.1.6

Obesity and Health Care Practitioners

Participation of the medical community will be required to initiate large-scale prevention
and treatment programs for obesity (Volkow & Wise, 2005). There are various provider
level barriers that influence the management of obesity in primary care. Primary care
practitioners may have a perceived inability to change patient behaviours, negative
attitudes toward obese patients, a belief that patients are not interested or ready for
treatment, or a belief that obesity is the responsibility of the patient (Forman-Hoffman et
al., 2006). Furthermore, practitioners commonly have a lack of formal training in
nutrition, obesity and weight management counseling (Forman-Hoffman et al., 2006).
Few clinicians (23.6%) report learning beneficial obesity management practices in
medical school and residency training programs (Forman-Hoffman et al., 2006). Weight
management education would be beneficial to make obesity a higher priority for health
care providers (Forman-Hoffman et al., 2006). The engagement of obstetricians,
pediatricians and family physicians will aid in the prevention of obesity for the next
generation (Volkow & Wise, 2005). More formal training for physicians, nurses,
psychologists and social workers is required for improved management and prevention of
obesity (Volkow & Wise, 2005).
It is unknown whether health behaviour and dietary counseling led by practitioners
actually motivates patient behaviour (Forman-Hoffman et al., 2006). Patients and
clinicians alike express the need for increased ease of access to obesity educators,
dieticians, physical therapists and behavioural counselors for a well-rounded approach to
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health and weight management (Forman-Hoffman et al., 2006). Research demonstrates
that many primary care clinicians do not regularly counsel or refer obese patients to
weight management services (Forman-Hoffman et al., 2006). In one study, personal
dietary vigilance by clinicians impacted the likelihood of regularly calculating the BMI of
obese patients, with more vigilant clinicians being more likely to calculate BMI (FormanHoffman et al., 2006). There is conflicting literature as to the effect of weight
management counseling initiated by clinicians who have a personal history of obesity.
One study found that these clinicians were more likely to provide obesity counseling to
patients (Epstin & Ogden, 2005). On the contrary, another study concluded that patients
were more receptive to health counseling provided by non-obese physicians (Epstin &
Ogden, 2005).
More often than not, primary care practitioners are not properly trained in the
management of obesity. A well-rounded team of formally trained physicians, nurses,
psychologists, social workers and kinesiologists is ideal to initiate and manage obesity
treatment and prevention programs.

1.2 Maternal Obesity in Pregnancy
There has been a significant rise in the incidence of obesity among pregnant women,
consistent with the increasing number of obese individuals (Hillier et al., 2007;
Hiramatsu et al., 2000; Katzmarzyk et al., 2008); about 50% of women of childbearing
age (20 to 34 years) are overweight or obese (Nascimento et al., 2012). In Canada alone,
the number of overweight and obese women of childbearing age has increased by 80,409
in a four-year span from 2008 to 2012 (Statistics Canada, CANSIM, 2013).
Consequently, the occurrence of pediatric obesity (among infants 0-11 months) in Canada
is increasing at a frightening rate (Plourde, 2006). An overweight or obese child has a
predisposition towards obesity as an adult (Shankar et al., 2008; Vanasse et al., 2006),
which is bound to have critical consequences on Canadian health care as a generation of
these obese children mature. Healthy lifestyle interventions targeting school-aged
children occur too late to prevent childhood obesity (Wardle et al., 2006). Clinical
research, therefore, suggests that prevention of obesity be initiated as early as pregnancy
(Plourde, 2006). The Institute of Medicine (IOM) has outlined a specific range of
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recommended gestational weight gain for obese women, based on pre-pregnancy BMI,
with both the welfare of the infant and health of the mother being priority (Institute of
Medicine, 2009). The antenatal period provides an opportunity to manage weight to
reduce both maternal and fetal complications associated with excessive weight gain and
maternal obesity (Nascimento et al., 2012).
Maternal obesity in pregnancy can lead to a lifetime of unhealthy weight for mother and
baby (Mottola et al., 2010). Excessive weight gain during pregnancy is often followed by
maternal weight retention postpartum, and these are independent predictors of long-term
weight gain and obesity (Phelan et al., 2011). The cycle of excessive gestational weight
gain and postpartum weight retention continues with each pregnancy thereafter, causing
BMI to increase with each new child born, thus increasing the health risks associated
with obesity. Pregnancy presents a time of powerful emotional, social, identity and
physical changes, as well as a new awareness that maternal behaviour may impact
offspring health (Phelan et al., 2014). This new awareness during pregnancy may provide
an incentive for women to adopt healthy nutrition and physical activity behaviours
(Phelan et al., 2014). Aggressive preventative management is recommended for all
overweight and obese women prior to pregnancy, during pregnancy and after delivery to
reduce the risk of pregnancy complications and health issues for both mother and baby in
the future (American College of Obstetricians & Gynecologists, 2005). The increasing
prevalence of maternal obesity demands an even more rigorous intervention strategy
carried out by a team of health care practitioners to properly manage treatment in an
obese pregnant woman.

1.2.1

Maternal Obesity Increases Pregnancy Complications

There are numerous medical complications associated with maternal obesity that may
arise during pregnancy. Depending on pre-pregnancy BMI, an increased risk of
macrosomia (birth weight >4.0 kg), augmentation of labour, gestational hypertension and
neonatal metabolic abnormalities can occur (Davies et al., 2010). With maternal obesity
there is an increased rate of fetal anomalies, one being neural tube defects (Davies et al.,
2010). One study reported a two-fold increase in neural tube defects in the offspring of
obese women (Nuthalapaty & Rouse, 2004). A dose response was also noted, with
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heavier women having an even higher risk (Nuthalapaty & Rouse, 2004). Repeat
ultrasounds may be required for women with a BMI above the 90th percentile and
obstetricians should consider BMI when scheduling a fetal anatomic assessment in the 2nd
trimester (Davies et al., 2010; Wolfe et al. 1990). Earlier ultrasounds may be optimal for
high-risk, high BMI pregnancies to detect abnormalities sooner rather than later.
Further pregnancy complications include spontaneous abortion, more severe forms of
preeclampsia, and gestational diabetes mellitus (GDM). The obese population is at an
increased risk of recurrent early miscarriages (Lashen et al. 2004). The most prevalent
risk factor for unexplained still birth is pre-pregnancy obesity (Fretts, 2005). Fetal and
uterine monitoring are challenging intrapartum complications, due to the maternal pannus
and difficulty transducing fetal heart rate and maternal contractions (Davies et al., 2010).
Maternal obesity is associated with an increased rate of Caesarean sections due to
macrosomia and the possibility of shoulder dystocia (Davies et al., 2010). Caesarean
section rates were 14.3% for lean women (BMI<19.8kg/m2) and 42.6% for very obese
women (BMI≥35.kg/m2) (Perlow & Morgan, 1994; Wall et al., 2003). Furthermore,
obese women undergoing Caesarean section experience more complications, which may
include blood loss >1000mL, increased operative time, increased postoperative wound
infection and endometritis, and the need for vertical skin incision (Perlow & Morgan,
1994; Wall et al., 2003). Obstetric anesthesia complications and the risk of epidural
failure are increased in obese women (Davies et al., 2010). Multiple attempts at catheter
placement for anesthesia may also be required (Davies et al., 2010).

1.2.2

Maternal Obesity Increases Childhood Obesity Risk

Maternal obesity in early pregnancy may increase the risk of offspring obesity in
childhood, adolescence, and adulthood (Laitenen et al., 2012). Maternal weight gain >7.0
kg during the first half of pregnancy is associated with a nearly 1.5-fold increased risk for
a child to be overweight or obese in adolescence (Laitenen et al., 2012). Statistics
indicate that children of obese mothers are twice as likely to be large for gestational age
at birth, and are more likely to be obese at preschool age (Hiramatsu et al. 2000; Mottola
et al., 2010). Moreover, research suggests that early exposure to certain diets during fetal
life can influence the food preferences of an individual later in life (Mennella et al. 2004;
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Volkow & Wise, 2005). Childhood obesity has repeatedly shown to be a strong predictor
of adult obesity (Flynn et al., 2006; Plourde, 2006), particularly in those children who are
overweight and experience adolescent obesity or have at least one parent who is obese
(Flynn et al., 2006).
There is growing research demonstrating the in utero environment is a predictor of future
neonatal, child and adult health risks (Simmons, 2008). Data consistently suggest that
excessive maternal weight gain and pre-pregnancy BMI have been correlated with birth
weight (Mottola, et al., 2010). Overweight and/or obese women are at an increased risk of
giving birth to larger babies (>90th percentile), even after controlling for GDM (Nomura
et al., 2012; Shankar et al., 2008). The odds of an infant weighing more than 4.0kg at
birth was 1.7 times greater for obese mothers and 2.0 times greater for obese mothers of
Class 2/3 (Bellver et al., 2003). Maternal obesity has been shown to be an independent
risk factor for macrosomic infants (Artenisio, et al., 1999). Excessive gestational weight
gain may also predict macrosomia as the majority of Canadian women (58%) who gained
more weight than recommended gave birth to an infant weighing 4.0 kg or more (Lowell
& Miller, 2010). Furthermore, a 1kg increment in birth weight in full-term infants was
associated with an approximate increase of 50% in the risk of the child being overweight
at ages 9-14 years (Gillman et al., 2003).

1.2.3

Maternal Obesity and Gestational Diabetes Mellitus (GDM)
Risk

Excessive maternal weight gain is associated with a substantially higher risk of GDM
(Chu et al., 2007), as an elevated BMI is a major risk factor for developing GDM
(Davenport et al., 2010). A positive relationship exists between BMI and maternal
glucose disorders. Davenport et al. (2010) noted that as pre-pregnancy BMI increased,
the prevalence of maternal glucose disorders also increased. GDM diagnosis during
pregnancy has been associated with increased Caesarean section deliveries due to the
incidence of large for gestational age (LGA) babies, as well as gestational hypertension
(Davenport et al., 2010). GDM affects 3-4% of Canadian pregnancies and this statistic is
on the rise due to the obesity epidemic and decreasing physical activity (Canadian
Diabetes Association, 2003; Catalano et al., 2009; Dempsey et al., 2004; Dempsey et al.,
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2004A; Ferrara, 2007; Jovanovic & Pettitt, 2001). In London, Canada, the prevalence of
GDM has increased by 52%, while the incidence of type 2 diabetes has increased by
206% between 2000 and 2009 (Davenport et al., 2010).
The diagnostic criteria for GDM remain controversial and the 2013 CDA guidelines
differ from those of the American Diabetes Association (ADA, 2013; CDA, 2013). The
2013 CDA expert committee chose a preferred approach and an alternate approach to
screening GDM. The preferred approach begins with a 50 mg glucose challenge test, and
if appropriate, is followed up with a fasted 75 g oral glucose tolerance test (OGTT).
GDM is diagnosed with ≥1 abnormal value. The increased maternal and perinatal
morbidity associated with GDM resulted in both the CDA and ADA guidelines outlining
GDM screening as standard of care for all women, despite risk factors (CDA, 2013).
There is escalating evidence of long-term complications, such as obesity and diabetes, in
children of women with maternal obesity and GDM (Hiramatsu et al., 2000). These longterm complications can include an increased risk of developing obesity, impaired glucose
tolerance, type 2 diabetes and chronic disease (Dunger et al., 2007; Hillier et al., 2007).
Emerging evidence suggests that maternal pre-pregnancy BMI is one of several key
factors that influence childhood weight gain and adiposity (Baker et al., 2004; Catalano et
al., 2009; Whitaker, 2004). Maternal pre-pregnancy BMI is significantly associated with
abnormal fetal growth, and further, childhood overweight and obesity (Catalano et al.,
2009). While maternal obesity is commonly linked to macrosomic infants, obese women
with a BMI >30 kg/m2 are also at risk for having a pregnancy complicated by a small
birth weight infant (Leddy et al., 2008). The “catch-up growth” phenomenon links small
birth weight infants to early onset obesity and the subsequent emergence of metabolic
syndrome with increasing age. Stroeschu et al. (2014) found an increased prevalence of
metabolic syndrome in those born small compared to appropriate for gestational age
growth starting at puberty.
In a cohort of low income children, maternal obesity during pregnancy more than
doubled the risk of obesity in children (Whitaker, 2004). Hyperglycemia during
pregnancy, a consequence of GDM, is correlated with obesity in children aged 5-7 years
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(Hillier et al., 2007), while childhood obesity is associated with a dramatic increase in the
prevalence of chronic disease (Flynn et al., 2006). Risk factors for chronic cardiovascular
disease, specifically hypertension, as well as impaired glucose tolerance, dyslipidemia
and hyperinsulemia have all been identified in obese children as young as 5 years (Csabi
et al., 2000; Flynn et al., 2006). The combination of obesity and chronic disease are
undeniably early risk factors for future morbidity in adulthood (Plourde, 2006). Maternal
nutrition and physical activity are incredibly important during pregnancy as they impact
the offspring risk of developing obesity and metabolic disease (Catalano et al., 2009).
Physical activity during pregnancy in particular has been shown to significantly reduce
the risk of GDM (Davies et al., 2010).

1.2.4

Physical Activity During Pregnancy in Non-Obese Women

Pregnant women seek medical care more readily and are often highly motivated to make
healthy lifestyle changes (Artal et al., 2007). Not only does a lifestyle intervention
program using nutrition and exercise reduce pregnancy weight gain, it also improves
pregnancy outcomes and can have a significant impact on future behaviours (Artal et al.,
2007). Pregnancy, therefore, provides an ideal time to make lasting lifestyle changes
(Artal et al., 2007). Unfortunately, pregnancy has also been associated with a sharp
decline in exercise and an increase in sedentary behaviour (Gaston and Cramp, 2011).
Few pregnant women are meeting exercise guidelines due to a decrease in frequency and
intensity from pre-pregnancy to pregnancy (Gaston and Cramp, 2011). For pregnancy
specifically, a commonly cited barrier is fatigue (Gaston and Cramp, 2011).
A growing body of literature suggests women be encouraged to participate regularly in
physical activity during pregnancy (Davies et al., 2003). Physical activity during
pregnancy has numerous benefits in addition to the prevention of excessive weight gain,
some of which include improved psychological well-being (Hartmann & Bung, 1999),
improved response to a carbohydrate load (Jovanovic-Peterson & Peterson, 1996),
decreased incidence of macrosomic babies resulting in delivery complications (Pivarnik,
1998) and quicker recovery following delivery (Giroux et al., 2006). Exercise during
pregnancy is associated with higher cardiorespiratory fitness, prevention of low back
pain, decreased symptoms of depression, and decreased insulin use for those with GDM
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(Nascimento et al., 2012). The literature consistently indicates that physically active
pregnant women feel better and experience fewer symptoms (including shortness of
breath, backaches, headaches, vomiting and hot flashes) associated with pregnancy
(Gaston and Cramp, 2011).

1.2.5

Assessing Physical Activity Readiness During Pregnancy

The Canadian Society for Exercise Physiology has developed a Physical Activity
Readiness Medical Examination for Pregnancy (PARmed-X) tool as a guideline for
health screening prior to participation in prenatal exercise. PARmed-X for pregnancy is a
convenient checklist for health care providers to evaluate patients and can be used for
ongoing medical surveillance during pregnancy (PARmed-X for Pregnancy, CSEP,
2013). PARmed-X for pregnancy prescribes a prenatal fitness program based on the FITT
principle (frequency, intensity, time and type of exercise). In terms of aerobic exercise, it
is recommended that pregnant women exercise three to four times weekly at a moderate
intensity (Davies et al., 2003; PARmed-X for Pregnancy, CSEP, 2013). Intensity of
exercise should be monitored using a combination of a target heart rate range and a rating
of perceived exertion (RPE) scale. Lower target heart rate zones are recommended for
pregnant women with a pre-pregnancy BMI of >25kg/m2 with a target range of 102-124
beats per minute (bpm) for a maternal age of 20-29 years, and 101-120 bpm for a
maternal age of 30-39 years (Davenport et al., 2008). Pregnant women should attempt to
exercise for 15 minutes, even if it means reducing the intensity. Rest intervals may be
incorporated. Non-weight bearing or low-impact endurance exercises using large muscle
groups (e.g., walking, stationary cycling, swimming, aquatic exercises, low impact
aerobics) is recommended, preceded by a brief warm up and followed by a short cool
down (PARmed-X for Pregnancy, CSEP, 2013).

1.2.6

Pregnancy Weight Gain Guidelines

To improve maternal and child health outcomes, women should aim to remain within the
projected pregnancy weight gain recommendations. The Institute of Medicine (2009) has
issued pregnancy weight gain guidelines based on BMI (see Table 2). Underweight
women (<18.5 kg/m2) are recommended to gain 12.7-18.1 kg during pregnancy at a rate
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of 0.45 kg/week. Normal weight women (18.5-24.9 kg/m2) are recommended to gain
11.3-15.9 kg at a rate of 0.45 kg/week. Overweight women (25.0-29.9 kg/m2) are
recommended to gain 6.8-11.3 kg at a rate of 0.32 kg/week. Lastly, obese women (≥30.0
kg/m2) are recommended to gain 5.0-9.0 kg at a rate of 0.27 kg/week (Institute of
Medicine, 2009). These calculations assume a 0.5-2.0 kg weight gain in the first trimester
(Institute of Medicine, 2009). A range of weight gain is necessary because a single
number cannot accommodate factors such as age and race/ethnicity that may affect
pregnancy outcomes.
Table 2: Recommendations for total and rate of weight gain during pregnancy by
pre-pregnancy body mass index (BMI)
Pre-pregnancy BMI

BMI

Total weight gain

Rates of weight gain

range (kg)

2nd and 3rd trimester
(maximum kg rate
per week)

Underweight

<18.5

12.7-18.1

0.45

Normal weight

18.5-24.9

11.3-15.9

0.45

Overweight

25.0-29.9

6.8-11.3

0.32

Obese (includes all

≥30.0

5.0-9.0

0.27

classes)
Source: IOM, 2009
Those who are obese at the time of conception are recommended to gain less pregnancy
weight in total compared to a woman of normal weight (Institute of Medicine, 2009). A
substantial number of pregnant women surpass these goals (Polley et al., 2002). In a
study of over 4000 women from the University of California, 70% of overweight (BMI
≥25 kg/m2) women exceeded the recommendations (Polley et al., 2002). In another study,
42% of women gained excessively according to the Institute of Medicine recommended
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guidelines (Olson et al., 2003). Lastly, Pereira et al. (2007) found that 52.7% of women
in all BMI categories had excessive gestational weight gain. Canadian statistics reveal
similar findings. Women with a higher pre-pregnancy BMI were more likely than normal
or underweight women to gain more weight than recommended during pregnancy
(Lowell & Miller, 2010). Fifty-five % of overweight/obese pregnant women gained more
than the IOM gestational weight gain guidelines, compared with 41% of those who were
normal weight and 25% who were underweight (Lowell & Miller, 2010).
Few pregnant women report being counseled correctly regarding weight gain and the
risks associated with excessive gestational weight gain by their health care practitioner
despite the revised 2009 IOM guidelines. Only 28.5% of the women reported their health
care provider made a recommendation about how much weight they should gain, while
25% reported being told the risks of inappropriate or excessive weight gain (McDonald et
al., 2011). A mere 12% of the women achieved the recommended weight gain in
accordance with the 2009 IOM guidelines (McDonald et al., 2011).
A significant number of patients (51.3%) reported that gestational weight gain was not
discussed at all during their first prenatal appointment, while 44.8% of patients reported
that exercise during pregnancy was not discussed (McDonald et al., 2011). Evidently,
there is a need for better patient education to improve the knowledge deficit for many
pregnant women regarding the recommended weight gain guidelines (McDonald et al.,
2011). Tovar et al. (2010) found similar results while evaluating the knowledge about
gestational weight gain in Hispanic women; a group typically found to have higher
obesity rates. The majority of the overweight and obese women reported that they had not
received any recommendations from physicians for weight gain during their pregnancy
(Tovar et al., 2010). For those who received gestational weight gain education, pregnancy
weight gain advice was not always consistent with IOM guidelines and was found to vary
widely (Tovar et al., 2010).

1.2.7

New Literature in Pregnancy Weight Gain Guidelines

New research has just recently suggested that IOM weight gain guidelines are just that –
recommendations that reserve the right to be individualized on a case by case basis,
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taking into account known risk factors. This matter is complicated by the American
Congress of Obstetrics and Gynecology committee, who recently suggested there may be
potential benefits of gaining below guidelines for an obese woman, as long as the fetus is
growing at a healthy rate (Kapadia et al., 2015). However, accurate clinical estimation of
fetal growth using ultrasound is especially difficult in obese women and may not always
be reliable.
Kapadia et al. (2015) aimed to determine the risk of adverse pregnancy outcomes with
GWG below 2009 IOM guidelines and within the guidelines in obese women. Primary
outcome measurements were preterm birth, small for gestational age (SGA) and large for
gestational age (LGA). SGA was defined as birth weight less than 3rd and less than 5th
percentile for sex and gestational age, while LGA was defined as birth weight >95th and
>97th percentile for sex and gestational age. GWG below the guidelines had higher odds
of preterm birth and SGA babies and lower odds of LGA than GWG within the
guidelines.
Swank et al. (2014) conducted a retrospective cohort study where super obese women
(BMI ≥50 kg/m2) were stratified to below, within and above IOM GWG guidelines.
Weight gain below IOM guidelines was not associated with statistically significant
increased odds of preterm birth or small babies, while LGA was significantly reduced for
the super obese women. Excessive weight gain statistically increased odds of pregnancy
induced hypertension and Cesearean delivery, while not reducing odds of small birth
weight babies. Swank et al. (2014) suggested that minimal weight gain in this population
is not detrimental to fetal growth, and may actually be protective against the development
of macrosomia. In summary, the study found that women with BMI ≥50 kg/m2 may
warrant individualized GWG recommendations.
As previously mentioned, it is recommended that obese women gain 5-9 kg during
pregnancy. It is interesting to note that gaining the lower limit of this range would
actually result in maternal weight loss following birth, since approximately 6 kg of
weight gained during pregnancy can be attributed to additional extracellular fluids, blood,
amniotic fluid, growth of the uterus and breast tissue, and the placenta (Kapadia et al.,
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2015). It is difficult to recommend GWG below the 2009 IOM guidelines considering the
lack of research as of late, as well as the increased risk of small birth weight and preterm
birth. GWG should be monitored closely, taking into account IOM recommendations and
individual risk factors.

1.2.8

Excessive Gestational Weight Gain and Weight Retention

For many women, obesity is initiated by an excessive weight gain during pregnancy
(Clark and Odgen, 1999). Numerous studies have found that pre-pregnancy weight is a
strong predictor of 12-month post-partum weight retention (Hartmann & Bung, 1999;
Moher et al., 2012). Overweight and obese women retain more weight post-partum
versus normal weight women (Harmann & Bung, 1999; Moher et al., 2012). A higher
pre-pregnancy weight is also associated with exceeding weight gain goals in accordance
with IOM recommendations (Nohr et al., 2008).
Women in the normal, overweight and obese BMI categories who gained excessively
during pregnancy retained significantly more weight at one year post-partum (Olson et
al., 2003). Statistics Canada reports that women who gained more weight than
recommended during their pregnancy retained more weight (4.5 kg on average) than
women who gained within (2.0 kg) or below the 2009 IOM recommendations (0.5 kg)
(Lowell & Miller, 2010). Clark and Odgen (1999) reported that women who later went on
to develop morbid obesity following pregnancy had already gained 4 kg more than the
control women at a mere 6 weeks post-partum. Overweight and obese women may
require more intensive lifestyle interventions to reduce excessive gestational weight gain
and weight retention than normal weight women (Phelan et al., 2014). This is particularly
true for obese women because of the more restricted recommended range of weight gain
(Phelan et al., 2014).

1.2.9

Maternal Obesity Management

All pregnant women, including those who are obese, are advised to keep gestational
weight gain within the IOM recommended parameters (classified by pre-pregnancy
BMI) to improve the health and well-being of both mother and baby. The Canadian
Obesity Network recently released a guide for practitioners titled the “5 A’s of Healthy
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Pregnancy Weight Gain,” addressing how to manage obese pregnant women in
particular. After weight gain recommendations have been established early in pregnancy,
it is important to identify and discuss the “root causes” of obesity itself, as well as the
myths and barriers associated with managing gestational weight gain. Barriers may
include environmental, socioeconomical, emotional, medical or cultural factors, as well
as physical barriers or physical discomfort (e.g. lack of sleep, mobility issues which may
hinder participation in daily activities). Practitioners must understand a woman’s cultural
context to fully understand her behaviours and provide an effective intervention, as
pregnancy-related health beliefs can be powerful influences on weight gain. Offering
credible resources and education are essential to improve understanding and weight selfmanagement. Evidence supports an interdisciplinary team approach for successful weight
management (Canadian Obesity Network, 2013). Depending on the identified
complications of excessive weight gain and/or the barriers to weight management during
pregnancy, providers may include general practitioner, obstetrician, midwife, nurse,
dietician, exercise physiologist, psychologist and social worker. Given the prevalence of
excessive weight gain and the subsequent high probability of post-partum weight
retention, pregnancy is an ever more critical period for obese women.

1.2.10

Difficulty of Behaviour Change and Obesity

Various interventions combining physical activity, nutrition and healthy gestational
weight gain guidelines have been implemented for normal weight women. A large
number of these intervention studies were unfortunately not successful at reducing mean
gestational weight gain and preventing excessive gestational weight gain based on IOM
guidelines. One potential reason that gestational weight gain interventions may have
success among normal weight women but not obese women is that overweight and obese
pregnant women may have unique barriers that require a more intensive intervention.
Many factors that may influence weight gain during an obese pregnancy in particular are
related to behaviour (energy intake, physical activity), psychological factors (attitude,
perceived control, intention), sociodemographic issues (age, parity) and physical factors
(BMI) (Savage et al., 2014).
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Renault et al. (2014) recently assessed gestational weight gain in obese pregnant women
using a physical activity intervention with or without dietary intervention. There was no
significant difference found between the two interventions, and the additive effect of the
dietary intervention was not significant. Compliance was an issue in the study as a large
part of the participants did not follow the dietary or physical activity advice. If only
compliant participants were measured, the weight reduction of the intervention group
may have been more pronounced. In a review by Pearce et al. (2013), only three
interventions of the ten randomized control trials included reported statistically
significant differences between the intervention and control groups. Unfortunately,
compliance was not consistently reported in the review and it remains unknown if
participants were adherent to the interventions. Findings suggest that there is little known
about the efficacy of interventions for obese pregnant women.
Few interventions have had success specifically targeting gestational weight gain in
overweight and obese pregnant women. Shirazian et al., (2010) developed a prenatal
intervention for obese women consisting of six seminars and individual counseling
sessions promoting healthy eating, walking and obesity education during pregnancy.
Obese women in the intervention group gained less weight than those in the standard care
group (8.1 ± 7.4 kg versus 15.3 ± 7.5 kg, p=0.003) (Shirazian et al., 2010). A limitation
of the study was that physical activity and eating habits were not reported. Shirazian et al.
(2014) later conducted another intervention revolving around educational and individual
counseling sessions focused on diet, exercise and weight goals. The free program began
in the first trimester and consisted of six group seminars, one-on-one counseling and
telephone calls. Fifty % completion of food diary and pedometer recordings were
emphasized. The curriculum aimed to educate women on obesity and pregnancy, promote
healthy eating and encourage walking as exercise. Barriers to a healthy lifestyle were
addressed and all participants met with a dietician at least once during prenatal care.
GWG was lower in participants versus control group, though not significant. The number
of sessions attended was associated with a decrease in total weight gain, demonstrating
participant attendance is key (Shirazian et al., 2014).
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Nascimento et al. (2011) conducted weekly aerobic dance classes of moderate intensity,
with recommendations about weekly physical activity and healthy gestational weight gain
for both overweight and obese women. A lower mean gestational weight gain was seen in
the intervention group (10.0 ± 1.7 kg) versus control (16.4 ± 3.9 kg, p=0.001), but only
for overweight women (Nascimento et al., 2011). Physical activity levels of women in the
control group were not reported.
An intervention including only obese women implemented by Claesson et al. (2008)
focused on behaviour change via motivational interviews and individual counseling
sessions, and physical activity in the form of aqua aerobic classes 1-2 times per week.
The intervention group gained less weight (8.7 ± 5.5 kg) compared to the control group
(11.3 ± 5.8, p <0.001) (Claesson et al., 2008). Seventy-eight % of intervention
participants actively participated in the counseling sessions and aqua aerobic classes once
per week.
McGiveron et al. (2014) developed an intensive health education program around diet
and exercise, titled the Bumps and Beyond Intervention for obese pregnant women. The
program offered one-to-one guidance and monitored dietary change while comparing 89
intervention women to 90 non-intervention women. The intervention group gained less
weight than the non-intervention group (4.5 kg vs 10.3 kg, respectively). Twenty-one %
of the intervention group lost weight during pregnancy. Women in the intervention group
must have attended 7/8 sessions to be included in analysis. The researchers concluded
that women must perceive the benefits of physical activity and healthy eating to
ultimately change their lifestyles (increase level of physical activity and reduce unhealthy
eating) (McGiveron et al., 2014).
Phelan et al. (2014) conducted behaviour interventions via telephone that targeted
gestational weight gain, healthy eating and exercise. The intervention increased the
percentage of women achieving pre-pregnancy weight at 12-months postpartum (35.4%
vs 28.1%) and significantly reduced the weight retained (1.4 kg vs 3 kg) compared to the
control group, respectively. Seventy-nine % of participants completed the study through
12 months postpartum.
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In a review of physical activity (PA) and physical activity plus diet interventions in
managing weight among overweight or obese pregnant women, Choi et al. (2013)
concluded that PA plus diet interventions are most effective in managing weight
regardless of body weight status in pregnant women. In addition, Phelan et al. (2011)
concluded that the best weight control strategies for both non-pregnant and pregnant
women appears to be the combination of PA and caloric management, with the addition
of behavioural strategies including frequent self-monitoring of diet and body weight.
Phelan et al. (2011) examined weight control literature of the past 30 years outside of
pregnancy to identify the key components of effective programs to potentially apply the
research to managing weight in the pregnant population. The researchers argue that
effective weight control strategies outside of pregnancy may also promote better weight
control and prevent excessive weight gain during pregnancy. The key components of
effective programs included use of caloric restriction, daily diet self-monitoring, selfweighing, behaviour therapy and ongoing patient-provider contact. Phelan et al. (2011)
reported that several clinical trials have found that structured meal plans, which
simplifies food selection and shopping for patients, improves adherence to calorie goals
and improves long-term weight loss outcomes. In terms of physical activity in the nonpregnant population, it was found that long-term results were better in home based
exercise programs, including the use of pedometers, to improve adherence. Weight
control literature in the non-pregnant population suggests that daily self-monitoring of
diet and body weight improves adherence, accountability and motivation.
In a randomized trial in early pregnancy, Harrison et al. (2014) found regular selfweighing combined with a self-management intervention optimized weight gain at 28
weeks gestation (5.66 ± 2.6 kg vs 7.03±3.56 kg) and reduced post-partum weight
retention (0.57 ± 3.94 kg vs 1.48 ± 5.49 kg) compared with control participants. The selfmanagement intervention focused on self-directed changes to lifestyle behaviours, goal
setting and problem solving skills. Intervention participants were encouraged to plot their
GWG on a chart and self-weigh regularly.
Research continually suggests that pregnant overweight and obese women require more
than advice; supervised and personalized programs and goals are needed to prevent
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excessive weight gain (Choi et al., 2013). Continued patient-provider contact (≥2
visits/month) seems to provide patients with the support and motivation required to
continue to practice weight control behaviours (Phelan et al., 2011A).
A mild exercise (i.e., walking program) in obese patients is beneficial when used in
combination with a nutritional program monitoring carbohydrate intake, to limit
gestational weight gain (Artal et al., 2007). The inclusion of mild exercise is
advantageous during pregnancy because dietary control alone may reduce not only fat
mass but also fat-free mass (Mottola et al., 2010). A reduction in fat-free mass in
combination with a lack of physical activity in obese women may lead to insulin
resistance, impaired glucose tolerance and possibly GDM (Mottola et al., 2010). As a
result, Mottola et al. (2010) devised a lifestyle intervention program incorporating both
dietary control and physical activity to prevent excessive pregnancy weight gain in
overweight and obese women. The Nutrition and Exercise Lifestyle Intervention Program
(NELIP), designed at the Exercise and Pregnancy Lab, Western University, London,
Canada, has since been posted as best practice on the portal website from the Public
Health Agency of Canada; http://cbpp-pcpe.phac-aspc.gc.ca/interventions/nutritionexercise-lifestyle-intervention-program/. NELIP was implemented at 16-20 weeks
gestation and reduced excessive weight gain with minimal weight retention at 2 months
postpartum in overweight and obese women, with an 80% success rate (Mottola et al.,
2010). It has been shown that pregnancy weight gain during the first 20 weeks of
gestation is predictive of total weight gain (Polley et al., 2002). Therefore, it may be
possible to identify women in early pregnancy that may be at risk for exceeding weight
gain recommendations, allowing for early nutrition and exercise counseling and
interventions (Polley et al., 2002). It would be advantageous to begin the intervention
earlier in gestation (12-16 weeks rather than 16-20) to prevent excessive weight gain
(Mottola et al., 2010).
Ultimately, there is limited research on gestational weight gain control in obese (class
2/3) women. Literature suggests that pregnant women of normal BMI are often highly
motivated to make lifestyle changes, thus pregnancy provides an ideal time to initiate a
lifestyle intervention program. It is unknown if this remains true for obese women.
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Research supports a multidisciplinary team approach of health care providers to improve
care for obese pregnant women, who have unique and challenging barriers. Behavioural,
psychological and physical barriers discussed previously may require a more intensive
intervention. Literature routinely suggests that the best weight control strategy for both
nonpregnant and pregnant women alike is a combination of PA and a dietary
intervention. However, as previously mentioned, Renault et al. (2014) found that the
additive effect of a dietary intervention on top of a PA intervention was not significant in
controlling excessive GWG in obese pregnant women, contrary to what one would
expect. While dietary control and physical activity is an ideal combination to prevent
excessive GWG, it may not be a practical solution for obese pregnant women. Perhaps
pregnancy is not the ideal time to make intensive lifestyle changes in the obese
population because of the unique barriers these women face. Obese women may have
difficulty with two behaviour changes (healthy nutrition and increased exercise
simultaneously) and may find one lifestyle change easier to achieve (either nutrition or
exercise) than both of these behaviour changes at the same time. The current pilot study
has been designed to investigate how to better manage GWG and pregnancy outcomes
for class 2/3 obese pregnant women.
Objectives of the current pilot trial include assessing feasibility, exploring the practical
application for a pivotal randomized controlled trial, and evaluating the logistics of the
trial (Loscalzo, 2009). Results obtained may be used to optimize the design in subsequent
studies, and may help guide the effective use of limited (financial and non-financial)
resources essential for a successfully performed intervention in the future (Loscalzo,
2009).
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Chapter 2

2

Purpose

The primary purpose of the current pilot study was to investigate the efficacy of an
evidence-based laboratory program, known as the Nutrition and Exercise Lifestyle
Intervention Program (NELIP), in the clinical setting. The specialized clinical setting
chosen was “My Clinic” located at the London Health Sciences Centre (LHSC) that
provides specialized care for those women with a pre-pregnancy BMI of ≥ 35 kg/m2 and
who have an increased obstetric risk for complications. A secondary purpose was to
determine if a specialized clinic improved outcomes for obese pregnant women in
London, Ontario.
Advanced care at My Clinic includes twice monthly clinic visits, additional ultrasounds
for fetal assessment and oral glucose tolerance tests at first visit (extra), 28 weeks
(usually done between 24 and 28 weeks) and 34 (extra) weeks gestation. These extra
visits, assessments and tests are not routinely done in standard care. My Clinic care uses a
team approach offering patients specialized obstetrical care, social work, and the
expertise of a dietician and a kinesiologist. Patients of My Clinic have regular meetings
with a dietician on staff where they receive education on Canada’s Food Guide and
healthy eating tips. A social worker and kinesiologist are available for patients if deemed
appropriate or beneficial.
To determine if My Clinic care improved pregnancy outcome measures in women with
class 2/3 obesity, those receiving My Clinic standard care were compared to a sanitized
(no personal information) perinatal database (receiving no specialized obstetric care)
containing information on birth outcomes in the City of London. The perinatal database
was analyzed to determine whether maternal obesity class 2 and 3 (pre-pregnancy BMI
≥35 kg/m2) is an issue regarding perinatal outcomes compared to those women with a
pre-pregnancy BMI < 35 kg/m2 that may necessitate specialized obstetrical clinic care.
Rates of obesity and birth outcomes for women who delivered a singleton baby in
London were evaluated.
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In order to examine the efficacy of the NELIP in the My Clinic clinical setting, women
recruited from My Clinic were randomized into one of three groups: 1) Women who
received the full NELIP; 2) Women who received only the nutrition component of
NELIP; or 3) Women who received only the exercise component of NELIP. GWG and
pregnancy outcomes were compared between the three groups and to those women
receiving standard care from My Clinic who did not want to be randomized but were
willing to provide their clinic data for analyses. Comparing these three randomized
groups to standard care at My Clinic also justified if an additional intervention (either full
NELIP, Nutrition only or Exercise only) was necessary in addition to standard care at the
specialized clinic to help prevent excessive GWG and to assess the resultant pregnancy
outcomes. Comparison of the three randomized groups determined if one behaviour
change (Nutrition alone or Exercise alone) is more efficacious for obese pregnant women
than two behaviour changes (full NELIP) in preventing excessive GWG.

2.1 Hypotheses
1. It was hypothesized that women receiving standard care at My Clinic would have
better outcome measures; decreased incidence of macrosomia (babies born >4.0
kg), small birth weight babies (<2.5 kg) and pregnancy complications than those
not receiving specialized standard care at My Clinic (perinatal database).
Pregnancy complication was defined by the number of Caesarean sections (yes or
no).
2. It was hypothesized that women receiving full NELIP at My Clinic would have
better success in preventing excessive GWG, reduction in macrosomia, small
birth weight babies, and pregnancy complications than those receiving Nutrition
alone, Exercise alone, or standard care at My Clinic.
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Chapter 3

3

Methodology

3.1 Perinatal Database
Ethics approval from the Human Research Ethics Boards for Health Sciences at Western
University and the London Health Science Centre was obtained (Appendix A1) for
analyzing the sanitized perinatal database from medical records containing maternal
characteristics and perinatal outcomes for all singleton births in London, Canada between
January 1 and December 31, 2011. Women with incomplete data (i.e., lacking height, or
pre-pregnancy weight), smokers, drug users, and those who consumed alcohol were
removed from the dataset. Women diagnosed with type 1 and type 2 diabetes prior to
pregnancy, and those who developed GDM were also removed from the data set. The
remaining women defined the perinatal database and were stratified by those with a prepregnancy BMI<35 and those with a BMI ≥35 kg/m2. Those women meeting study
inclusion criteria with a BMI ≥ 35 kg/m2 were used as a matched cohort control group.
Caesarean section (yes/no) and infant birth weight were recorded. However, maternal
gestational weight gain was not available in the dataset.

3.2 Standard Care Procedure at My Clinic
Standard care My Clinic patients completed a self-reported Weight and Health History
Questionnaire (Appendix A2) during their initial visit to the clinic. From this
questionnaire, self-reported pre-pregnancy weight was recorded from the patient file.
Height was measured and also recorded in the patient file. All women were medically
pre-screened by their obstetrician for contraindications to physical activity using the
PARmed-X for Pregnancy (2013; Appendix A3). The height and pre-pregnancy weight
measurements were used to calculate pre-pregnancy BMI (kg/m)2. My Clinic patients had
appointments in the clinic every two weeks on average. Weight was charted at each visit
to monitor rate of weight gain as well as total gestational weight gain. Patients received
three fasted oral glucose tolerance tests (OGTT) throughout their pregnancy. All women
who had no contraindications to physical activity were approached to participate in the
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randomized control trial (RCT; see below) and those women who did not wish to
participate in the RCT (see below) signed informed consent (Appendix A4) to be
considered as the My Clinic standard care group. Those in My Clinic standard care were
offered Canada’s Food guide and healthy eating tips but did not receive a structured meal
plan from dietician. Those receiving My Clinic standard care were encouraged to exercise
by their obstetrician but were not given a formal exercise program.

3.3 My Clinic Randomized Controlled Trial
Women were recruited for the pilot RCT from My Clinic standard care patients who met
the above criteria. The Human Research Ethics Boards for Health Sciences at Western
University and the London Health Science Centre approved the RCT protocol (Appendix
A1), and all women gave informed written consent to participate in the RCT. This trial
was registered at www.clinicaltrials.gov, NCT02155751.

3.3.1

Participants

Women over the age of 18 years, with a pre-pregnancy BMI of ≥ 35 kg/m2 (class 2 and 3
obese), between 12 and 20 weeks gestation were recruited to participate in the study
through self-referrals and family physician referrals to My Clinic. In order to participate
in the study, women had no contraindications to walking, did not have type 1, type 2
diabetes, or GDM at baseline, and were nonsmokers.

3.3.2

Randomization

CONSORT (Consolidated Standards of Reporting Trials) guidelines were followed to
generate the random allocation sequence using a random numbers table. CONSORT
ensures proper design and execution of the RCT to avoid bias or exaggerated treatment
effects (Moher et al., 2012). The SNOSE (sequentially numbered, opaque sealed
envelopes) (Doig & Simpson, 2005) method was chosen for random allocation to the
different treatment groups: full NELIP, Nutrition only or Exercise only.
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3.3.3

Intervention Procedure at My Clinic

If patients did not have GDM at their initial fasted OGTT at 12-20 weeks gestation, they
were eligible to participate in the study. Following consent, each participant completed a
3-day food intake record (Appendix A6) and a 7-day pedometer log (Appendix A7) for
baseline measurements. The 3-day food intake records were analysed for nutritional
information (total energy per day and daily macronutrient intake) using a nutrition
program (ESHA Food Processor SQL software). Once the 3-day food intake record and
the pedometer log sheets were collected, the women were assigned at random to one of
the study groups (full NELIP, Nutrition-only, or Exercise-only).
Participants assigned to the Nutrition-only component of NELIP were taught a specific
meal plan (Appendix A8) by the My Clinic dietician (trained in the NELIP protocol) to
promote healthy eating habits, regulate blood sugar levels and control excessive GWG.
The dietary program was similar to the gestational diabetic meal plan designed to: a)
individualize total energy intake with a minimum of 2000 kcal/day (8360 kJ/day), taking
into account the usual energy intake as indicated by each dietary assessment (including 3day food intake record) with a restriction of not more than 33% total energy intake; b)
adjust if necessary the total carbohydrate intake to 40-50% of total energy intake,
distributing carbohydrate intake throughout the day with three balanced meals, and three
snacks per day emphasizing complex carbohydrates and low glycemic index foods; c)
adjust the total fat intake to 30% of total energy intake (substituting monounsaturated
fatty acids for saturated and trans-fatty acids), with the remaining 30% dedicated to
protein intake; and d) meet all micronutrient and fluid needs recommended during
pregnancy (Mottola et al. 2010).
Participants in the Nutrition-only group recorded their 24-hour food and drink intake
once per week and met with the dietician at each clinic visit to determine whether
adjustments in the nutrition program were required as pregnancy progressed. These
weekly food intake logs were handed in to the dietitian and analysed using the ESHA
Food Processor SQL software. Women in this group were given no formal exercise
advice, (except to be active as standard care for the women in My Clinic), no pedometer
to record steps, and no exercise self-monitoring during the intervention.
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Participants assigned to the Exercise-only component of NELIP began a controlled
walking program. Participants walked for 25 minutes per session, 3 to 4 times per week,
adding 2 minutes each week to the session until 40 minutes was reached and then
maintained until delivery (Mottola et al. 2010). Daily steps were recorded using a
pedometer and log sheet (Appendix A7) to keep track of daily steps and to initiate selfmonitoring behaviour. An easy and maintainable walking pace was encouraged to avoid
becoming breathless. Participants had the option of attending the clinic once per week for
a monitored walk with an exercise specialist, or completing walks at home (whether that
be on a treadmill, an outdoor trail, in their neighbourhood, etc.). Pedometer log sheets
were handed in to the exercise specialist at each clinic visit. As part of standard care at
My Clinic the participants in the Exercise-only group met with the clinic dietitian at each
scheduled My Clinic visit and were given information on Canada’s Food Guide and
healthy eating tips. These women did not receive the NELIP meal plan, nor did they
complete or record (self-monitor) their food intake.
Participants assigned to the full Nutrition and Exercise Lifestyle Intervention Program
(NELIP) were introduced to both the dietary and walking program, including the selfmonitoring for both nutrition and exercise, described above.
All participated in the programs from 12-20 weeks until delivery and were weighed at
each visit to the clinic, on average twice monthly, similar to standard care at My Clinic.
Infant birth weight, APGAR scores and pregnancy and/or delivery complications were
obtained from medical charts. Within 6-18 hours after birth (before the women left the
hospital), a member of the research team visited the participant in hospital and measured
the length of the newborn within 0.1 cm and recorded all other birth information from the
chart.

3.4 Outcome Measurements
Maternal anthropometric measurements were taken from each patient’s chart and
included height (cm), pre-pregnancy weight (kg), and last measured weight prior to
delivery (kg) to calculate gestational weight gain (weight prior to delivery (kg) – prepregnancy weight (kg)). Total gestational weight gain (kg) and rate of weight gain
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(calculated per week) were used to determine whether there was a significant difference
between the three NELIP groups and those receiving standard care at My Clinic.
The incidence of macrosomia was assessed as the number of babies born >4.0 kg (Artal
et al., 2007). Macrosomia incidence rates were compared between the three groups of
NELIP women vs. My Clinic standard care women, and those not receiving My Clinic
care (information from the London, ON perinatal database).
Pregnancy complications were also assessed between the three groups of NELIP women,
My Clinic standard care, and the perinatal database. Pregnancy complication was defined
as Caesarean section (yes/no).

3.5 Statistical Analyses
Participant characteristics were compared between the perinatal database, My Clinic
specialized standard care, and My Clinic NELIP participants (that also received the My
Clinic specialized standard care). Continuous data (i.e. maternal height, maternal prepregnancy weight, maternal pre-pregnancy BMI, maternal gestational weight gain, infant
weight) were compared using an ANOVA. ANOVA and Student’s t-tests were used to
compare pedometer step-counts and nutrition data between the three randomized groups
at baseline and to compare pre data to data collected while on the intervention for each
individual group. Data were presented as mean ± standard deviation. Categorical infant
data (small birth weight (yes/no), macrosomia (yes/no), C-section rate (yes/no)) were
compared using a chi-squared test. Statistical significance was set at p≤0.05.
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Chapter 4

4

Results

4.1 Perinatal Database
A total of 4565 women were removed from the dataset due to incomplete data (i.e.,
lacking height, or pre-pregnancy weight), smokers (N=139), drug users (N=76), and
those who consumed alcohol (N=25) and women diagnosed with type 1 and type 2
diabetes prior to pregnancy (N=8), leaving 834 women for the final analysis. A total of
39 women developed GDM during pregnancy (approximately 5%) (N=23 GDM diet
controlled, N=13 GDM insulin controlled, N=3 no information how they controlled their
GDM) and were also removed from the dataset for final analyses. Interestingly, the mean
pre-pregnancy BMI for those that developed GDM was 31.3 ± 6.6 kg/m2. Twenty-six %
of those that developed GDM had a BMI ≥ 35 kg/m2 (N=10).
Average birth weight for all infants born to mothers of all BMI classifications in the
perinatal database (N=834) was 3.4 ± 0.6 kg. Average gestational age was 38.6 ± 2.4
weeks. Macrosomia (>4.0 kg birth weight) incidence for mothers of all BMI
classifications was 14% (N=117). Small birth weight (<2.5 kg) incidence was 8%
(N=69). The Caesarean section rate for mothers of all BMI categories was 27.8%
(N=232).
The remaining women (N=834) were stratified by BMI<35 (N=787) and ≥35 kg/m2
(N=47). The 47 women meeting study inclusion criteria with a BMI ≥ 35 kg/m2 were
used as a matched control group to My Clinic participants.
The women in the matched control group were 30.9 ± 4.1 years old, 164 ± 6.6 cm tall,
with a pre-pregnancy body mass of 106.5 ± 15.0 kg and a pre-pregnancy BMI of 39.2 ±
4.4 kg/m2. Average infant birth weight was 3.5 ± 0.8 kg, while gestational age was 38.4 ±
2.5 weeks. Maternal gestational weight gain was unfortunately not included in the
database. Macrosomia incidence was 27.7% (N=13). Small birth weight incidence was
6.4% (N=3).
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Chi-square analysis revealed a difference in macrosomia incidence between the women
in the perinatal database with a pre-pregnancy BMI of ≥ 35 kg/m2 (27.7%) and those
women with a BMI of < 35 kg/m2 (12.6%; p=0.03). The rate of small birth weight babies
for women with a pre-pregnancy BMI of ≥ 35 kg/m2 (6.4%) did not differ from those
women with a BMI of < 35 kg/m2 (7.6%; p=0.58).
The Caesarean section rate for infants of mothers with a BMI ≥ 35 kg/m2 was 40.4%
(N=19), while the Caesarean section rate for infants of mother’s with a BMI <35 kg/m2
was 22.4%; p=0.007. For those with a BMI ≥ 35 kg/m2 there were three cases of forceps
deliveries (6%) and one vacuum delivery (2%). Five infants (10.6%) had fetal
complications and were admitted to the Neonatal Intensive Care Unit (NICU). For those
with a BMI <35 kg/m2 there were 59 cases of forceps deliveries (7.5%) and 24 cases of
vacuum deliveries (3%), and 114 (13.1%) had fetal complications and were admitted to
the NICU.

4.2 My Clinic Standard Care vs Perinatal Database
Twenty-one women consented to be included as patients representing standard care for
My Clinic. The women were 30.8 ± 7.1 years old, 165 ± 6.2 cm tall, with a pre-pregnancy
body mass of 123.1 ± 23.2 kg and a pre-pregnancy BMI of 45.2 ± 7.3 kg/m2. Average
infant weight was 3.4 ± 0.5 kg, while gestational age was 38.7 ± 1.4 weeks. Average
parity for this group was 0.9 ± 1.4. Macrosomia incidence was 5.3% (N=1) and there
were no cases of small birth weight infants.
Chi-square analysis revealed a difference in macrosomia incidence between My Clinic
standard care (5.3%) and perinatal database women with a pre-pregnancy BMI ≥ 35
kg/m2 (27.7%; p=0.000), and standard care was not different than those women from the
perinatal database with a BMI < 35kg/m2 (12.6%; p=0.112). There was a significant
difference in small birth weight babies between My Clinic standard care and the perinatal
database (none vs 6.4%, respectively; p=0.000). The Caesarean section rate for infants
born to mothers of My Clinic standard care was 38% (N=8), and was not significantly
different than the Caesarean section rate of the women in the perinatal database with a
pre-pregnancy BMI ≥ 35 kg/m2 (see Table 3).
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Table 3 My Clinic standard care women compared to women in the Perinatal
Database with a pre-pregnancy body mass index of ≥35 kg/m2
Group

My Clinic

Birth

Birth

C-section

Macrosomia

Small birth

Weight

Length

(#/%)

(#/%)

weight (#/%)

(kg)

(cm)

3.4 ± 0.5

N/A

8/38.1%

1/5.3%†

0/0%**

3.5 ± 0.8

N/A

19/40.4%

13/27.7%

3/6.4%

Standard Care
N=21

Perinatal
Database N=47

Birth length was not available
† My Clinic standard care vs perinatal database ≥ 35 kg/m2, p=0.000
** My Clinic standard care vs perinatal database ≥ 35 kg/m2, p=0.000
Total gestational weight gain for the My Clinic standard care group was 7.6 ± 7.1 kg,
within the IOM’s 2009 recommendations for obese women (IOM, 2009). Weight gain
prior to the first appointment at My Clinic was 1.8 ± 8.8 kg. Women received My Clinic
standard care for 20.0 ± 8.8 weeks. Weight gain while attending the clinic was 6.4 ± 4.9
kg, while the rate of weight gain was 0.4 ± 0.4 kg/week. Fifty-five % of the women
gained excessive weight while receiving My Clinic care (N=12). For four of these women
(33%), excessive weight gain occurred prior to their first appointment at My Clinic at
18.1 ± 5.9 weeks gestation.

4.3 My Clinic Intervention (RCT)
A total of 26 women were recruited to participate in the RCT and signed consent
(Appendix A5). Three women developed GDM prior to 20 weeks gestation, before
randomization, and were removed from the study (exclusion criteria). Eleven women
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withdrew from the study prior to randomization. Twelve women agreed to participate and
met the inclusion criteria (see Figure 1). They were randomized into one of three groups.
Four women were allocated to the nutrition only group, and one dropped due to the
severity of her Crohn’s disease flare ups with the meal plan. Five women were allocated
to the exercise only group, and two dropped due to the required time commitments. Three
women were allocated to the full NELIP and all withdrew due to a combination of
factors, including pain when exercising, leaving My Clinic care for midwifery care, and
the time commitments required, resulting in a drop out rate of 100%. Ultimately, only 6
women in total completed the program for the entire duration of pregnancy.

Figure 1: Randomization flow chart for My Clinic research patients
1

GDM – gestational diabetes mellitus

Baseline data consisting of a three-day food intake record (Table 4) and seven-day
pedometer log (Table 5) were collected for the RCT women. There was no statistical
difference between the groups at baseline.
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Table 4 Baseline data: Average daily three-day food intake record data for
participants (N=6) prior to randomization.
Group

Total
Energy

PRO

CHO

%

%

%

(kcal)

(g)

(g)

Fat (g)

Protein

CHO

Fat

2535.6 ±

93.8 ±

321.0 ±

102.2 ±

14.6 ±

47.8 ±

37.6 ±

1286.5

36.3

159.5

70.4

3.7

9.7

9.1

3385.5 ±

122.9 ±

411.25

148.45 ±

12.5 ±

1871.7

45.4

± 185.1

112.1

0.7

1969 ±

74.5 ±

260.9 ±

71.4 ±

595.7

14.2

142.0

8.9

Participants
(N=6)

Nutritiononly (N=3)

44.5 ±
43 ± 4.2 5.0

Exerciseonly (N=3)

16 ± 4.4

51 ±

33 ±

11.8

8.7

PRO – protein
CHO – carbohydrate
No statistical difference between the groups at baseline
Table 5 Baseline data: Average daily step counts from seven-day pedometer record
for participants prior to randomization.
Participants (N=6)

6340.1 ± 2443.7

Nutrition-only (N=3)

7167.5 ± 4532.8

Exercise-only (N=3)

5895.6 ± 628.9

No statistical difference between the groups at baseline.
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The six women who completed their respective intervention program were 31.3 ± 5.4
years old, 164.3 ± 5.9 cm tall, with a pre-pregnancy body mass of 123.3 ± 18.6 kg and a
pre-pregnancy BMI of 44.1 ± 5.5 kg/m2. Infant weight was 3.51 ± 0.55 kg, and infant
length was 52.6 ± 4.8 cm, while gestational age was 38.8 ± 2.9 weeks. The incidence of
macrosomia (>4.0 kg) for infants of My Clinic intervention participants was 15% (N=1).
There were no cases of small birth weight infants (<2.5 kg). Two women had C-sections
(33.3%), and one woman had a forceps delivery. One infant of an intervention participant
(N-only) had fetal complications and as a result was admitted into NICU.
Average parity was 1.0 ± 2.4. Total gestational weight gain for intervention participants
was 7.5 ± 10.6 kg, within the IOM guidelines for obese women (IOM 2009). An average
weight loss of 1.2 ± 5.5 kg occurred prior to beginning the intervention at 12-20 weeks
gestation. Weight gain on the 20.6 ± 2.9 week long intervention was 7.5 ± 10.6 kg, while
the rate of weight gain was 0.38 ± 0.27 kg/week. Fifty % of the women did not gain
excessive weight (N= 3). Fifty % gained excessively (N=3), and for two of these women,
excessive weight gain occurred prior to beginning the intervention at 16-20 weeks
gestation. If excessive weight was not gained prior to the intervention the success rate
would increase from 50% to 83%.
The 3 women who participated in the Nutrition-only intervention were 27.0 ± 3.0 years
old with a pre-pregnancy body mass of 127.1 ± 26.5 kg and a pre-pregnancy BMI of 46.2
± 7.4 kg/m2. Infant birth weight was 3.64 ± 0.6 kg, infant length was 52.4 ± 4.0 cm,
infant BMI was 13.2 ± 0.7, and gestational age was 39.7 ± 1.2 weeks. Total gestational
weight gain was 14.6 ± 5.7 kg, above the IOM guidelines for obese women (IOM 2009).
The rate of weight gain during the intervention was 0.6 ± 0.1 kg/week. The drop-out rate
for the Nutrition only intervention was 25% (1/4). The average nutritional data (Table 6)
revealed a significant increase (p=0.04) in % of total energy intake from protein between
baseline food intake records and records obtained during the ongoing Nutrition-only
intervention. The % of calories from fat did not change while following the meal plan,
however there appeared to be a reduction of 36% compared to baseline records (p=0.07).
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Table 6 Average nutrition data at baseline compared to the Nutrition-only
intervention at the end of the program
Total
Energy

PRO

CHO

(kcal)

(g)

(g)

%

%

Fat (g)

Protein

CHO

Pre-

3385.5

intervention

±

122.9 ±

411.3 ±

148.5 ±

12.5 ±

(baseline)

1871.7

45.4

185.1

112.1

0.7

Nutrition-only

1769.9

90.55 ±

232.2 ±

56.45 ±

intervention

± 27.3

1.3

22.9

13.7

Effect size

0.52

0.45

0.56

0.49

20 ± 0*

% Fat

44.5 ±
43 ± 4.2

5.0

51.5 ±

28.5 ±

6.4

6.4**

* Intervention different from baseline, p=0.04
** p=0.07
Medium effect size = 0.3 - 0.5
The three women who participated in the Exercise only intervention were 35.7 ± 2.9
years old with a pre-pregnancy body mass of 119.5 ± 10.8 kg and a pre-pregnancy BMI
of 42.0 ± 3.0 kg/m2. Infant birth weight was 3.4 ± 0.6 kg, infant length was 52.2 ± 5.7
cm, infant BMI was 12.4 ± 1.2, and gestational age was 38.0 ± 3.6 weeks. Total
gestational weight gain in the exercise only intervention was 0.4 ± 9.9 kg (within the
IOM guidelines; IOM, 2009). The rate of weight gain during the intervention was 0.2 ±
0.1 kg/week. The drop-out rate for the exercise only intervention was 40% (2/5).
Participants doubled their daily step counts (Table 7), though not significant (p=0.18).
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Table 7 Average daily step counts at baseline compared to Exercise-only
intervention at the end of the program
Pre-intervention (baseline)

5895.6 ± 628.9

Exercise-only intervention

11900.8 ± 2659.8

Effect size

0.84

No statistical difference between baseline and Exercise-only intervention
Large effect size = ≥ 6.0
Although there was no significant difference in average total weight gain between the
groups (see Table 8), there was a difference trending towards significance (p=0.09)
between the My Clinic Exercise-only group (0.4 ± 9.9 kg) compared to the Nutrition-only
(14.6 ± 5.7 kg) group. The average rate of weight gain was significantly less in the
Exercise-only group (0.2 ± 0.1 kg/week) compared to both My Clinic standard care (0.4 ±
0.4 kg/week; p=0.04) and the Nutrition-only (0.6 ± 0.1; p=0.01) groups.
Birth weight was not different between the groups (see Table 9). Chi-square analysis
failed to find a difference in C-section rates between patient groups from My Clinic.
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Table 8 Characteristics of women receiving Standard Care at My Clinic compared
to women receiving the intervention (Exercise only; E-only, or Nutrition only; Nonly)
Group

Prepregnancy
BMI
(kg/m2)

Age
(years)

Total
Weight
Gain (kg)

Rate of
Weight
Gain
(kg/week)

Gestational
Age
(weeks)

My Clinic 123.1 ±
Standard 23.2
Care
N=21

45.2 ± 7.3

30.8 ±
6.9

7.6 ± 7.1

0.42 ±
0.43‡

38.7 ± 1.4

My Clinic 119.5 ±
10.8
NELIP
E-only
N=3

42.0 ± 3.0

35.7 ±
2.9

0.42 ±
9.9**

0.2 ± 0.1*

38.0 ± 3.6

My Clinic 127.1 ±
26.5
NELIP
N-only
N=3

46.2 ± 7.4

27.0 ±
3.0

14.6 ± 5.7

0.6 ± 0.1

39.7 ± 1.2

+

Prepregnancy
weight (kg)

+

E-only different from N-only, p=0.02

* E-only different from N-only, p=0.01; **p=0.09
‡ Standard Care different from E-only, p=0.04.
NELIP – Nutrition and Exercise Lifestyle Intervention Program
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Table 9 Summary of weight gain between My Clinic groups and perinatal outcomes
between all groups
Group

Total

Rate of

C-section

Macrosomia

Small birth

Weight

Weight

(#/%)

(#/%)

weight (#/%)

Gain (kg)

Gain

N/A

19/40.4%

13/28%

3/6.4%+

0.4 ± 0.4‡

8/38.1%

1/5.3%††

0/0%

0.2 ± 0.1*

1/33.3%

0/0%

0/0%

0.6 ± 0.1

1/33.3%

1/33.3%

0/0%

(kg/week)
Perinatal

N/A

Database
N=47
My Clinic 7.6 ± 7.1
Standard
Care
N=21
My Clinic 0.4 ± 9.9**
NELIP
E-only
N=3
My Clinic 14.6 ± 5.7
NELIP
N-only
N=3
* E-only different from N-only, p=0.01; **p=0.09
‡ Standard Care different from E-only, p=0.04
†† My Clinic standard care different from perinatal database ≥ 35 kg/m2, p=0.02
+ My Clinic standard care different from perinatal database ≥ 35 kg/m2 vs E-only vs Nonly p=0.000
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Chapter 5

5

Discussion

For women with a pre-pregnancy BMI of ≥ 35 kg/m2 who were referred to a specialized
clinic (My Clinic) an intervention consisting of exercise only was better at preventing
excessive gestational weight gain than a nutrition intervention alone. Combining a
nutrition and exercise intervention appeared difficult for this population as 100% of the
women randomized to this group dropped out (although one woman changed to
midwifery care). It may be that the combination of a nutrition and exercise program
requiring two lifestyle behaviour changes (eating habits and physical activity) may be a
burden for this specialized group of obese women. Changing one behaviour, specifically
the addition of a walking program appeared to be best for this population group, as these
women were able to prevent excessive gestational weight gain. Standard care at My
Clinic appeared to reduce macrosomia rates and no babies were born small compared to
women with similar BMIs matched from the perinatal database.

5.1 Is there a need for My Clinic care?
Literature indicates that both patients and health care practitioners express a need for a
well-rounded approach to obesity and weight management (Forman-Hoffman et al.,
2006). Increased ease of access to a multidisciplinary team of health care providers will
benefit patients and physicians alike. Few primary care clinicians are regularly
counseling obese patients on weight management, as many lack the proper training in the
management of obesity as a whole, and more specifically, maternal obesity (FormanHoffman et al., 2006). McDonald et al., (2011) reported that few pregnant women were
counseled by their primary care physician according to the 2009 IOM weight gain
guidelines, and advised of the risks associated with excessive GWG. Only 28.5% of the
women in the sample survey at prenatal clinics reported their health care provider made
weight gain recommendations, while only 25% were made aware of the risks of
inappropriate or excessive weight gain. Despite the 2009 publication of the GWG
guidelines, only 12% of women reported being counseled correctly on weight gain
according to the IOM recommendations (McDonald et al., 2011). These statistics reveal
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an urgent need for improved patient care, especially in the obese population where the
risks associated with excessive GWG are even greater. In recognition of this, the
Canadian Obesity Network (2013) developed the ‘5 A’s of Healthy Pregnancy Weight
Gain’ as an education tool for health care practitioners to better manage obese pregnant
women. The program advises physicians to follow the 2009 IOM weight gain guideline
recommendations, and identify and discuss the root cause(s) of the patient’s obesity as
well as the barriers associated with managing GWG. An essential element of the
Canadian Obesity Network is patient education to improve self-management. The
Canadian Obesity Network concludes that evidence supports a multidisciplinary team
approach for successful weight management. Many of the recommendations from the ‘5
A’s’ have been purposefully adopted in My Clinic to better manage weight gain in the
pregnant obese population.
The model of behavior change, known as the Stages of Change (SOC) model, states that
individuals can be characterized as belonging to one of five ‘stages’ in respect to
changing chronic behavior patterns (Prochaska & Di Clemente, 1985). In precontemplation the individual does not intend to change their behaviour in the next six
months. An individual in the contemplation stage is strongly inclined to change
behaviour in the next 6 months. Preparation is characterized by an individual’s intention
to act in the near future (generally the next month). In the action stage the behaviour has
already been incorporated for at least six months. The individual incorporating the
behaviour for more than six months characterizes the maintenance stage, where the
likelihood of the old behaviour returning is low.
Literature supports interventions tailored to an individual’s specific stage of change to
improve effectiveness (Prochaska & Goldstein, 1991). My Clinic standard care aimed to
assist and guide women through the stages of change by implementing the 5 A’s of
healthy pregnancy weight gain and obesity management into standard care (Canadian
Obesity Network, 2013). The majority of women referred to My Clinic began in the precontemplation stage. In attempt to guide women into the contemplation stage
obstetricians first asked for patient permission to discuss patient’s current weight and
healthy pregnancy weight gain. The risks associated with the patient’s BMI and
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pregnancy were then assessed and communicated (advised). The benefits of a healthy
lifestyle were discussed with an emphasis on improving overall pregnancy outcomes for
both mother and baby. If the patient was ready to transition into the preparation stage,
realistic goals for appropriate pregnancy weight gain were discussed in a positive manner
and agreed upon in attempt to avoid patient self-disappointment and non-adherence. The
preparation stage also involved the obstetrician assisting the patient, which included but
was not limited to a dietician referral, exercise specialist referral, more frequent followup appointments, educational resources, etc.
The lack of training among primary care practitioners combined with the increasing
prevalence of maternal obesity justifies the need for My Clinic to better service obese
pregnant women. A team approach used at My Clinic was shown to better manage
obesity treatment and prevention than those not receiving the specialized My Clinic care
(perinatal database).
Analysis of the perinatal database determined that maternal obesity is an issue in London,
Canada, with an obesity rate of 18%. Six % of all pregnancies belonged to class 2/3 obese
women, necessitating specialized obstetrical care. Moreover, this 6% did not include
class 1 obese women nor class 2/3 obese women with GDM (as it was an exclusion
criteria), which would increase the percentage of obese pregnant women. It is concerning
that current evidence reveals that up to 72% of obese women have excessive GWG
according to current IOM recommendations (Faucher and Barger, 2015). There was a
marked difference between macrosomia incidence between the women in the perinatal
database with a pre-pregnancy BMI of ≥ 35 kg/m2 (27.7%) and those women with a BMI
of < 35 kg/m2 (12.6%), further justifying the need for more intensive obstetrical care.
Similarly, women in the perinatal database with a BMI ≥ 35 kg/m2 also had an increased
Caesarean section rate (40%) compared to women with a BMI <35 kg/m2 (23%).
While My Clinic standard care did not impact Caesarean section rates compared to the
perinatal database, rate of macrosomia (5.3% vs. 28%) and rate of small birth weight
infants (0% vs 6.4%) were reduced. Evidence over the long term has demonstrated that
macrosomia and small birth weight can lead to an increased risk of infants later
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developing metabolic syndrome and childhood obesity (Guelinckx et al., 2008). If My
Clinic care can decrease rates of macrosomia and small birth weight babies it may
potentially slow down the vicious cycle of obesity, diabetes and metabolic syndrome over
future generations. It is evident that My Clinic standard care played an important role in
delivering healthier babies of class 2/3 obese pregnancies compared to women who did
not receive the specialized obstetrical care (perinatal database).

5.2 NELIP – Did it work?
The second major objective of the present study was to determine if an evidenced-based
Nutrition and Exercise Lifestyle Intervention Program (NELIP) was an effective addition
to My Clinic standard care. Furthermore, the current study aimed to determine whether
one behaviour change (Nutrition alone or Exercise alone) would be a more realistic
intervention for class 2/3 obese pregnant women compared to two behaviour changes
(full NELIP). Considering the drop-out rate for the full NELIP was 100%, even though
NELIP is best practice, the full intervention may be too difficult for class 2/3 obese
women in the clinical setting. Adhering to a meal plan and recording food intake while
simultaneously incorporating and recording daily exercise may be too challenging and
ultimately may have led to withdrawal from the full intervention. Although one woman
switched to midwifery care, the other two women cited pain upon exercise and too great
of a time commitment.
Campbell et al. (2011) conducted a review to explore the factors influencing the
effectiveness of behaviour change interventions to prevent excessive gestational weight
gain. The authors reported limited effectiveness of interventions during pregnancy aimed
to prevent excessive weight gain, despite the interventions being personalized and
tailored on a case-by-case basis. Cited barriers of the interventions included fear of
harming the unborn baby, general physical discomfort, discouragement to undertake
physical tasks by people around them, and positive encouragement toward over eating
(Campbell et al. 2011). These factors were found to lead to a general decline in physical
activity and an increased risk of excessive gestational weight gain (Campbell et al.,
2011). General physical discomfort was often cited as a barrier to physical activity for My
Clinic women, and one woman dropped out of NELIP because of it. It is also a
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possibility, based on the high drop-out rates, that many participants were lacking the
support network required for the intensive lifestyle modifications of NELIP. The majority
of drop out participants cited the time commitment as the major barrier of the
intervention, although it would be interesting to explore this further and discuss their
individual support network (or lack thereof) in the future.
There was one significant difference in the recruitment process for the NELIP
intervention between the women studied in the laboratory setting and those in My Clinic.
Intervention participants in the laboratory NELIP were self-referred and contacted study
investigators after viewing study participation posters in midwifery/physician’s office
and/or around the campus of Western University. On the basis of self-referrals, laboratory
participants likely entered the study already in the contemplation stage of change. On the
contrary, NELIP participants in the My Clinic setting were directly referred by their
obstetrician and many remained in the pre-contemplation stage of change, which may
have led to failure to comply with the intervention or the high dropout rates.
Compared to the participants previously studied in the lab, the women at My Clinic were
specifically obese class 2 and 3. My Clinic women also experienced various
psychological issues such as depression and anxiety, which were frequently charted,
perhaps related to the lack of perceived control associated with pregnancy, vulnerability,
fear or past traumatic experiences (Campbell et al., 2011). Recording food intake and
daily pedometer steps, essential to compliance and self-monitoring, may have repeatedly
increased anxiety levels in this group of women, and anxiety was cited as a secondary
reason for withdrawal from the intervention on more than one occasion. Women
attending My Clinic were typically of lower socioeconomic status (as indicated from their
medical charts), many were unemployed or receiving social assistance (with a few
exceptions), which may differentiate this group of women from those studied in the lab.
Unfortunately, the combination of behavioural, physical, psychological and
sociodemographic factors (which were not measured in the present study) may have led
to the 100% drop out rate in the more intensive intervention (NELIP) group. Future
analyses should include all of these co-founding variables to assist in overcoming
potential barriers to lifestyle change in obese class 2 and 3 women.
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The more successful interventions of the study were those involving only one behaviour
change; either the nutrition or exercise only groups. The nutrition group had a drop-out
rate of 25%, while the exercise group had a drop-out rate of 40%. The exercise
intervention was most efficacious in reducing GWG and keeping weight gain within the
IOM guidelines. This may indicate that walking as the exercise modality, and as a single
behaviour change, may be the best intervention for obese class 2 and 3 women. A
walking intervention is an inexpensive method for increasing daily PA and can be easily
implemented into daily clinical practice. A mild exercise program is important because it
is an easier adjustment for obese women who were previously sedentary. Furthermore,
obese individuals may have difficulties with nutrition, thereby making exercise in the
form of walking or increasing daily step counts as a more realistic intervention.
Haby et al. (2015) recently conducted a pilot study using prescribed physical activity,
pedometers and walking poles to significantly reduce GWG in pregnant women with an
average BMI of 33.1 kg/m2 in a midwifery setting. Food advice was given and counseling
via a dietician was offered but the dietary program was not mandatory. Compliance
characteristics were low in this study, with only 34% of women participating in the food
discussion group and 50% using pedometers. Nonetheless, GWG was significantly lower
in the exercise intervention group.
Renault et al. (2014) had similar results to the current My Clinic study when assessing
GWG in obese pregnant women using a physical activity intervention with or without
dietary intervention. Renault et al. (2014) found no significant difference between the two
interventions, concluding that the additive effect of the dietary program was not
significant. Compliance was also an issue in the study as many participants did not follow
the dietary advice.
Although the nutrition intervention used a modified GDM meal plan combined with
walking and was shown to prevent excessive GWG in the laboratory setting (Mottola et
al. 2010), the nutrition component alone was not as effective as exercise in preventing
excessive GWG. While exercise was a simple addition to their daily lives, the nutrition
program was much more difficult to achieve. Non-compliance to the nutrition program
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and under reporting of what they ate may be issues that resulted in the 14.6 ± 5.7 kg
weight gain. Nevertheless, obese pregnant women might still benefit from regular visits
to a dietician in a specialized obesity clinic who would be familiar with the nutrition
recommendations for obese pregnant women.
Research indicates maternal obesity is an independent risk factor for macrosomia
(Artenisio et al., 1999). Class 2/3 obese women, specifically, have two times the odds of
delivering an infant >4.0 kg compared to women of a normal BMI (Bellver et al., 2003).
A 1.0 kg increment in infant birth weight was associated with a 50% increase in
childhood overweight/obesity at 9-14 years of age (Gillman et al., 2003). However,
literature has shown that a small decrease in maternal weight (one BMI unit) is enough to
decrease the risk of macrosomia (Villamor and Cnattingius, 2006). Prevention of
macrosomia is paramount in order to reduce the cycle of obesity for future generations.
Along with reducing GWG, the exercise intervention significantly reduced macrosomia
compared to My Clinic standard care. Both intervention groups along with My Clinic
standard care prevented small birth weight babies. Babies born small are at a greater risk
for obesity later in life, perhaps due to a period of catch-up growth, as well as an
increased cardiovascular risk later in life (Mottola et al., 2010). Reducing macrosomia
and small birth weight infants may perhaps be one step in preventing future childhood
obesity by providing a healthy fetal environment and pregnancy lifestyle change for
obese women.
Despite being best practice, the full NELIP including both diet and physical activity was
not a successful addition to My Clinic standard care. However, either component of the
intervention as a single behaviour change (i.e. Nutrition-only or Exercise-only) was
found to be beneficial in class 2/3 obese women at My Clinic. The exercise intervention
was found to best limit GWG and keep weight gain within IOM guidelines, as well as
significantly reduce the risk of macrosomia. Incorporating one behaviour change into
their lifestyle, rather than two, seemed to be most efficacious for class 2/3 obese women
at My Clinic.
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5.3 Strengths/Limitations and Future Directions
One strength of the current study was that it was designed to use an evidence-based best
practice intervention program for overweight and obese pregnant women known as
NELIP. NELIP in the laboratory setting had an impressive 80% success rate in
preventing excessive weight gain in overweight and obese women during pregnancy. The
exercise intervention and use of pedometers provided an inexpensive method for
increasing daily physical activity that was easy to implement in the clinical setting and
the delivery of the modified GDM diet with a specified meal plan was implemented by a
dietitian associated with the specialized clinic. Theoretically, the delivery of the
evidence-based intervention should have been complementary to the clinic setting.
However, there were several limitations to the current study. Several women from the
clinic were excluded because they were diagnosed with GDM early at the first visit
screen for standard care. This exclusion criteria was necessary but also decreased the
eligibility pool and lowered the number of women who agreed to participate in the study.
In addition, a homogenous population was used and all women were Caucasian, reducing
the risk of bias but also lowering external validity. There was a very wide range of weight
gain, indicating that participants likely did not adhere to the dietary and/or exercise
advice. The probability of underreporting of food intake and over reporting of pedometer
steps or frequency of exercise may have been high. Pre-pregnancy weight was selfreported, which may be slightly different than if it were directly measured. In addition,
the final sample size in the current study was small. The 2011 perinatal database was
used as a proxy for the women referred to My Clinic as the 2012/2013 databases were not
available at the time of data collection. Unfortunately, the 2011 perinatal database did not
adhere to the CDA guideline updates (2013), and it remains unknown if some of the
women in the perinatal database would have been diagnosed with GDM according to the
updated current criteria.
Another possible limitation of the current study was the lack of self-monitoring that
occurred in both the nutrition and exercise groups. The Nutrition-only group selfmonitored food intake, however they did not record step counts so it remains unknown
how active these women were. In addition, the Exercise-only group completed the
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exercise log with pedometer steps but did not monitor nutrition, although both groups had
access to My Clinic standard care with nutrition and exercise advice. To avoid burdening
the women they did not have to self-monitor both behaviours, as these results would have
been seen in the full NELIP group. Unfortunately, 100% of the women receiving the full
NELIP dropped out so the results of self-monitoring two behaviours remain unknown.
Future direction may include additional measurement of nutrition and exercise behaviour
without using self-monitoring of the behaviour not being changed. For example, in the
Exercise-only group, perhaps a food frequency questionnaire could be used at the
beginning and at the end of the study to capture change in nutrition behaviour and an
exercise questionnaire such as the Kaiser questionnaire validated for pregnant women
(Schmidt et al., 2006) could be used to capture change in exercise behaviour pre and post
intervention in all groups. In addition, future studies should be based on theories of
behaviour change specifically designed for obese class 2 and 3 pregnant women.
Many questions remain unanswered as to how to best approach multiple behaviour
change. Research is inconclusive and both sequential and simultaneous behaviour change
have shown success depending on the intervention and individual (Vandelanotte et al.,
2008). Perhaps participants would benefit from a tailored, individualized intervention
where they are able to choose how they wish to integrate the multiple behaviour changes
into their lifestyle (either sequentially or simultaneously).
Pregnant women attending My Clinic may have mental health issues including depression
and anxiety (personal observation). An integrative team approach to obstetrical care
should be continued at My Clinic, however, additional support of a social worker,
psychologist and/or psychiatrist could be beneficial in the antenatal treatment plan to
assist these women with the unique barriers they face related to class 2 and 3 obesity.
Literature reveals that individuals tend to engage in activities in which they believe they
can succeed – without confidence in their success one will not be successful (Savage et
al., 2014). Furthermore, research suggests individuals must perceive the benefits of
physical activity and healthy nutrition to ultimately change their lifestyles and be
compliant to an intervention (McGiveron et al., 2014). Unrealistic expectations regarding
weight management in obese individuals can often lead to disappointment and non-
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adherence (Canadian Obesity Network, 2011). Future intervention studies at My Clinic
may benefit from patient education workshops focusing on setting appropriate GWG
goals, with the emphasis on prevention of excessive weight gain, and problem solving
skills to overcome their unique barriers and time management skills. Workshops
previously provided by My Clinic in the group setting were lacking in attendance.
Perhaps this group of obese women may respond better to anonymity and may benefit
from one-on-one goal setting and time management counseling sessions in the future.
In a randomized trial, Harrison et al. (2014) found that regular self-weighing combined
with a self-management intervention optimized pregnancy weight gain compared to
control participants. Intervention participants in the trial were encouraged to plot and
track their weekly GWG on a chart. While My Clinic patients were weighed in the clinic
at all appointments, self-weighing was not necessarily encouraged. It remains unknown if
self-weighing would be efficacious for the My Clinic population and result in improved
self-management of obesity.
Evidence suggests pregnancy presents a new maternal awareness of the ability to impact
infant health (Phelan et al., 2014). Pregnant women are often highly motivated to make
healthy lifestyle changes and many argue that pregnancy is an ideal time to provide an
intervention to benefit both mother and infant (Artal et al., 2007). On the contrary,
research indicates that many women also feel that pregnancy is an opportunity to not
worry about their weight, which leads to increased caloric intake (Clark and Ogden,
1999). Both of these scenarios were indicated (personal observation) in the participants
from My Clinic and should be explored further in an attempt to find common themes.
Despite the challenges related to integrating NELIP in the My Clinic setting, the unique
intervention program should be continued for class 2/3 obese pregnant women at risk for
excessive weight gain and macrosomic babies. The non-pregnant and pregnant literature
concludes the best weight control strategies involve a combination of physical activity
and nutritional management, with the possible addition of behavioural strategies (Phelan
et al., 2011). However, obese class 2 and 3 pregnant women may have difficulty with two
behaviour changes simultaneously. As a result, obese women may find one intensive
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lifestyle change easier to achieve. These pilot results should be further pursued to explore
the efficacy of lifestyle interventions for obese class 2 and 3 pregnant women in the
clinical setting.
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Appendix A2 Weight & Health History Questionnaire

Unique Identifier: ___________________________

Today’s date: _______________________

Weight & Health History Questionnaire
Please answer the following questions to the best of your ability.
All of the answers gained through this survey will be held in the strictest of confidence.

Section A – Background Information:
1) What is your date of birth? _____________________ (month, day, year)
2) What is your ethnic background?
 Caucasian

 Hispanic

 Aboriginal (please circle: First Nations,

 Asian

 African American

 Other, please specify _________________

Métis,

Inuit )

3) What is your height? ____________ feet ____________ inches, OR ____________ centimeters
4) What education level did you complete? Please check all that apply.
 Elementary school

 High school

 College

 University (please circle: certificate, bachelor, master, doctorate)
 Other, please specify________________

Section B – Current Pregnancy:
5) What has been your usual adult body weight? ____________ pounds, OR ____________ kilograms
6) How much weight did you plan to gain during this pregnancy?
____________ pounds, OR ____________ kilograms
7) How much weight did you gain during this pregnancy?
____________ pounds, OR ____________ kilograms
8) What was your body weight one year before this pregnancy?
____________ pounds, OR ____________ kilograms
9) What was your body weight immediately before this pregnancy?
____________ pounds, OR ____________ kilograms

10) Were you actively trying to reduce your body weight in the year before this pregnancy?
1
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 No

 If Yes, how much weight did you lose? ____________ pounds, OR ____________ kilograms

11) What have your eating habits been like in the year before this pregnancy? Check all that apply.
 one meal per day, specify when ____________________________________
 two meals per day, specify when _____________________________________
 three meals per day
 snack(s) every day, specify when ______________________________________________
 Special diet, please specify name ___________________________________________________________
 Trying to follow Canada’s Food Guide to Healthy Eating
 Other nutrition plan, please specify
__________________________________________________________
12) What has your pattern of physical activity been like in the year before this pregnancy?
Type of

Frequency

Physical Activity

Average Duration

Intensity

Location

of your exercise

(low, medium, high)

(home, outdoors,

sessions
_________

gym, etc.)

_________ minutes

time(s) per week
_________

_________ minutes

time(s) per week
_________

_________ minutes

time(s) per week
_________

_________ minutes

time(s) per week

13) How would you qualify your current level of stress on most days?
 No stress.
 Low stress level.
 Moderate stress level.
 High stress level. You perceive it as a problem.
14) Was this your first pregnancy?
 No

 Yes

Section C – Previous Pregnancies:
2
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15) Please fill the following chart.
Age

Body weight you were

Weight you gained

you were

immediately before

during pregnancy

Weight retained after

pregnancy
1st pregnancy
nd

2 pregnancy
3rd pregnancy
th

4 pregnancy
5th pregnancy

pregnancy
(never really lost)

_________pounds,

_________pounds,

_________pounds,

OR __________kg

OR __________kg

OR __________kg

_________pounds,

_________pounds,

_________pounds,

OR __________kg

OR __________kg

OR __________kg

_________pounds,

_________pounds,

_________pounds,

OR __________kg

OR __________kg

OR __________kg

_________pounds,

_________pounds,

_________pounds,

OR __________kg

OR __________kg

OR __________kg

_________pounds,

_________pounds,

_________pounds,

OR __________kg

OR __________kg

OR __________kg

Other pregnancies: ____________________________________________________________________________
16) For each pregnancy, what were the gestational age, gender and approximate birth weight and length?
Gestational Age
st

1 baby

_________ weeks

Gender

Birth weight

Birth Length

_________pounds

_________inches,

___________ounces,

OR __________cm

OR __________kg
2nd baby

_________ weeks

_________pounds

_________inches,

___________ounces,

OR __________cm

OR __________kg
rd

3 baby

_________ weeks

_________pounds

_________inches,

___________ounces,

OR __________cm

OR __________kg
4th baby

_________ weeks

_________pounds

_________inches,

___________ounces,

OR __________cm

OR __________kg
5th baby

_________ weeks

_________pounds

_________inches,

___________ounces,

OR __________cm

OR __________kg
Other babies: _______________________________________________________________________________
17) Please indicate how you fed your baby(ies).
3
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Breastfeeding

Duration of

Age breastfeeding

started

breastfeeding only

was stopped

of first solid foods

1st baby

____ Yes, ____ No

_________ months

_________ months

_________ months

2nd baby

____ Yes, ____ No

_________ months

_________ months

_________ months

3rd baby

____ Yes, ____ No

_________ months

_________ months

_________ months

4th baby

____ Yes, ____ No

_________ months

_________ months

_________ months

____ Yes, ____ No

_________ months

_________ months

_________ months

th

5 baby

Age at introduction

Other babies: ____________________________________________________________________

Section D – Weight History:
18) What was your birth weight? ____________ pounds _____________ ounces, OR ____________ kilograms
19) What was your birth length? ____________ inches, OR ____________ centimeters
20) How has your body weight been since you were 19 years of age?
 stable (always about the same weight, only changing by a couple of pounds when I am not pregnant),
please skip to question 28
 unstable and progressively increasing
 unstable, because it has been going up and down often
 unstable, I feel I have been gaining weight with each pregnancy
 Other, please describe ______________________________________________________________
21) By how many pounds or kilograms does your body weight tend to fluctuate (or change) per year?
In average about ____________ pounds, OR ____________ kilograms per year.
22) What do you think causes your body weight to be unstable? Please explain.
_______________________________________________________________________________________
_______________________________________________________________________________________
_______________________________________________________________________________________
23) Have you ever actively tried to lose weight?
 Yes

 If No, please skip to question 28

24) How old were you when you first actively tried to lose weight? ____________________________________
4
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25) What method did you use when you first actively tried to lose weight?
__________________________________________________________________________________________
26) Since you were 19 years old, how many times have you been actively trying to lose weight and at what
ages? Please explain.
___________________________________________________________________________________________
___________________________________________________________________________________________
27) List all the methods you have tried to lose weight.
 Vitamin/mineral supplement, please specify __________________________________________________
 Dietary changes or special diets, please specify
________________________________________________
_____________________________________________________________________________________
 Physical activity, please specify ______________________________________________________
______
____________________________________________________________________________________
 Pills or herbal products, please describe _____________________________________________________
____________________________________________________________________________________
 Prescribed medication, please describe ______________________________________________________
____________________________________________________________________________________
 Surgery, please describe _________________________________________________________________
____________________________________________________________________________________
 Meetings with a health care professional(s), please indicate which professional(s) ____________________
____________________________________________________________________________________
 Other, please describe ___________________________________________________________________
____________________________________________________________________________________
28) What was the maximum weight you ever lost, how long did it take you to lose that weight and what method
did you use?
I lost ________ pounds, OR _________ kilograms in ___________ months, using the following method
____________________________________________________________________________________
29) Have you ever consulted a physician about weight issues or for weight management purposes?


No



No, but I would like to.
5
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Yes, and it was helpful. Explain ____________________________________________________



Yes, but it was not helpful. Explain _________________________________________________

30) Have you ever consulted a registered dietitian about weight issues or for weight management purposes?


No



No, but I would like to.



Yes, and it was helpful. Explain ____________________________________________________



Yes, but it was not helpful. Explain _________________________________________________

31) If you choose a method to lose weight in the future, what will you be looking for as important characteristics?
Check the three (3) most important factors for you.
 Group meetings

 Individual support

 Short-term results

 Long-term results

 Minimum time commitment

 Follow-up support

 Education

 Learning healthier lifestyle choices

 Expert advice by registered dietitian

 Expert advice by physician

 Expert advice by exercise physiologist
 Safety

 Cost
 Help with stress management

 Other, please specify _________________________________________________________

Section E – About Your Health:
32) Have you ever been diagnosed with:
Type 1 Diabetes Mellitus

 Yes

 No

Type 2 Diabetes Mellitus

 Yes

 No

Gestational Diabetes Mellitus

 Yes

 No

Pre-diabetes

 Yes

 No

Gestational hypertension

 Yes

 No

Polycystic Ovarian Syndrome

 Yes

 No

33) Do you currently, or have you ever taken medication for diabetes or pre-diabetes:
 No
 If Yes, please describe
__________________________________________________________

Section F – About Your Family:
34) How many siblings do you have?
_________ Sister(s)

_________ Brother(s)

 I do not know
6
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35) How many of your siblings are overweight or obese?
_________ Sister(s)

_________ Brother(s)

 I do not know

36) Is there a history of overweight or obesity in the rest of your immediate family? (Check all that apply)
 Your mother

 Your father

 Grandmother on your mother’s side  Grandfather on your mother’s side
 Grandmother on your father’s side
 None

 Grandfather on your father’s side

 I do not know

 Other(s), please

specify:______________________________
37) How many of your siblings have diabetes?
_________ Sister(s)

_________ Brother(s)

 I do not know

38) Is there a history of diabetes in the rest of your immediate family?
 Your mother

(Check all that apply)

 Your father

 Grandmother on your mother’s side  Grandfather on your mother’s side
 Grandmother on your father’s side
 None

 Grandfather on your father’s side

 I do not know

 Other(s), please

specify:______________________________
39) What is the height and weight of the father of your child to be?
Height ___________ feet ___________ inches, OR _________________ centimeters
Weight ___________ pounds, OR _______________ kilograms
40) What is the ethnic background of the father of your child to be?
 Caucasian

 Hispanic

 Aboriginal (please circle: First Nations,

 Asian

 African American

 Other, please specify _________________

Métis,

Inuit )

41) How many siblings does the father of your child to be have?
_________ Sister(s)

_________ Brother(s)  I do not know

42) How many of the father’s siblings are overweight or obese?
_________ Sister(s)

_________ Brother(s)

 I do not know

43) How many of the father’s siblings have diabetes?
_________ Sister(s)

_________ Brother(s)

 I do not know
7
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Appendix A3 PARmed-X for Pregnancy

Physical Activity Readiness
Medical Examination for
Pregnancy

ACTIVITY READINESS
PARmed-X for PREGNANCY PHYSICAL
MEDICAL EXAMINATION

PARmed-X for PREGNANCY is a guideline for health screening

.

A

PATIENT INFORMATION
____________________________________________________________________________________________________________________________________
_________________________________________________________________________________________________________________________________
______________________________

______________________

__________________________________________

__________________________________________

_________________________________

B PRE-EXERCISE HEALTH CHECKLIST

PART 3: ACTIVITY HABITS DURING THE PAST MONTH

PART 1: GENERAL HEALTH STATUS

____________________________________________________
____________________________________________________

+

Heavy

___
___
___

___
___
___

___
___
___

+

___
___
___

___
___
___

___
___
___

__________________________________________________________
_______

PART 2: STATUS OF CURRENT PREGNANCY
________________________________________________

PART 4: PHYSICAL ACTIVITY INTENTIONS
_________________________________________________________
th

I

th

_________________________________________________________

*NOTE: PREGNANT WOMEN ARE STRONGLY ADVISED NOT TO SMOKE
OR CONSUME ALCOHOL DURING PREGNANCY AND DURING LACTATION.

1
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Physical Activity Readiness
Medical Examination for
Pregnancy

PARmed-X for PREGNANCY MEDICAL EXAMINATION

PHYSICAL ACTIVITY READINESS

C

CONTRAINDICATIONS TO EXERCISE: to be completed by your health care provider
Absolute Contraindications

Relative Contraindications
❏

❏

❏

❏

❏

❏

❏

❏

❏

❏

❏

❏

❏

❏

❏

❏

❏

❏

❏

❏

❏

❏

❏

❏

❏

___________________________________________

❏

NOTE:

❏

❏

Prescription for Aerobic Activity
RATE OF PROGRESSION: The best time to progress is during the second

PRESCRIPTION/MONITORING OF INTENSITY: The best way to prescribe

HEART RATE RANGES FOR PREGNANT
WOMEN
WARM-UP/COOL-DOWN:

RATING OF
PERCEIVED
EXERTION (RPE)
your heart rate target

F

I

T

T

FREQUENCY

INTENSITY

TIME

TYPE

pregnant women.
6
8

an appropriate
progress to
heart rate

reducing the
intensity.
15
16

“TALK TEST”
18

No changes permitted. Translation and reproduction in its entirety is encouraged.

Hard
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Physical Activity Readiness
Medical Examination for
Pregnancy

PARmed-X for PREGNANCY MEDICAL EXAMINATION

PHYSICAL ACTIVITY READINESS

Prescription for Muscular Conditioning
It is important to condition all
major muscle groups during
both prenatal and postnatal
periods.

EXAMPLES OF MUSCULAR STRENGTHENING EXERCISES
CATEGORY

PURPOSE

EXAMPLE

muscle groups
(DO NOT OVER STRETCH!)

PRECAUTIONS FOR MUSCULAR CONDITIONING DURING PREGNANCY

supine position should be altered

develops
Posture

• emphasis on correct posture and neutral pelvic alignment.

accentuated lordosis and the posterior pelvic tilt position.
Precautions

should be avoided

PARmed-X for Pregnancy - Health Evaluation Form
_____________________________________
activity
___________________________________________

_________________________________
__________________________________________________
__________________________________________________________
_________________________________________________

____________________________________________

________________________________________________________
________________________________________________________
________________________________________________________
________________________________________________________
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Physical Activity Readiness
Medical Examination for
Pregnancy

Advice for Active Living During Pregnancy

Active Living:

Healthy Eating:

➤

➤
increasing your activity level
during pregnancy

Positive Self and
Body Image:
➤

remember that it is normal
to gain weight during
pregnancy

➤

accept that your body
shape will change during
pregnancy

➤

➤
➤
➤
program

➤

➤

➤

➤

➤

➤

dieting to lose weight is not recommended during
pregnancy

For more detailed information and advice about pre- and postnatal exercise, you may wish to obtain a copy of a booklet entitled Active Living During
Pregnancy: Physical Activity Guidelines for Mother and Baby © 1999. Available from the Canadian Society for Exercise Physiology,
www.csep.ca. Cost: $11.95
Public Health Agency of Canada. The sensible guide to a healthy pregnancy. Minister of Health, 2012. Ottawa, Ontario K1A 0K9. http://www.phac-aspc.
gc.ca/hp-gs/guide/assets/pdf/hpguide-eng.pdf. HC Pub.: 5830 Cat.: HP5-33/2012E. 1 800 O-Canada (1-800-622-6232) TTY: 1-800-926-9105.
Davenport MH. Charlesworth S. Vanderspank D. Sopper MM. Mottola MF. Development and validation of exercise target heart rate zones for overweight and obese pregnant women. Appl Physiol Nutr Metab. 2008; 33(5): 984-9.
Davies GAL. Wolfe LA. Mottola MF. MacKinnon C. Joint SOGC / CSEP Clinical Practice Guidelines: Exercise in Pregnancy and the Postpartum
Period. Can J Appl Physiol. 2003; 28(3): 329-341.
Mottola MF, Davenport MH, Brun CR, Inglis SD, Charlesworth S, Sopper MM. VO2peak prediction and exercise prescription for pregnant women.
Med Sci Sports Exerc. 2006 Aug;38(8):1389-95.PMID: 16888450

SAFETY CONSIDERATIONS

AND CONSULT YOUR
HEALTH CARE PROVIDER

the 1st trimester

th

pregnancy

athletic competition

REASONS TO STOP EXERCISE

82

Appendix A4 Letter of Information and Consent to Participate as a Control

May 14, 2012

Letter of Information
Investigation Title:

Bringing an evidence-based Nutrition and Exercise Lifestyle
Intervention Program (NELIP) for obese pregnant women into
clinical practice.

Study Investigators:
1. Dr. Debbie Penava, MD, FRCSC, Department of Obstetrics & Gynecology;
2. Dr. Michelle Mottola, PhD, Exercise and Pregnancy Lab, UWO;
3. Dr. Barbra deVrijer, MD, FRCSC, Department of Obstetrics & Gynecology
The purpose of this letter of information is to provide you with the information you need to make
an informed decision about participating in this study.
Introduction
You are being invited to participate in a research study looking at the effects of a nutrition and
exercise lifestyle intervention program (NELIP) in the prevention of excessive pregnancy weight
gain, and a reduction in the incidence of diabetes and cardiovascular disease risks, for mothers
and their offspring, through an early initiation of healthy living.
Purpose of the Study
The main goal of the study is to prevent childhood obesity early through a lifestyle intervention
aimed at at-risk pregnant women to prevent excessive weight gain during pregnancy and
gestational diabetes. There will be a total of 30 program patients and 30 controls enrolled in this
study.
Inclusion/Exclusion Criteria
In order to participate in this study, you must be a patient who has been referred to the
specialized “My Clinic” at the London Health Sciences Centre. You must also be:
• At least 18 years old
• 12-16 weeks pregnant
In order to participate in this study, you must not:
• Have a medical reason that would keep you from walking regularly.
• Have existing type 2 diabetes.
If you are unsure about whether you are eligible to participate in this study, please discuss with
your “My Clinic” physician.
Initials: _______
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May 14, 2012
Study Procedures
Oral Glucose Tolerance Test
If you are interested in participating in this study, we ask that you inform us before you have
your oral glucose tolerance test performed in the clinic. The oral glucose tolerance test
performed as part of standard care is slightly different than the one used for the study:
• The standard oral glucose tolerance test for patients at “My Clinic”: To prepare for this
test you must eat no food or drink anything except water for 12 hours (overnight) before
your visit. Once in the lab, we will draw 10mL of blood once you have been sitting
quietly for 20 minutes. Two more blood samples will be withdrawn after we have given
you a sweet liquid containing 75 g of glucose to drink. These samples will be taken at 60
and 120 minutes after you have taken the drink, while you are resting comfortably in a
chair. The total blood withdrawn from your vein is approximately 20 mL (less than 2
tablespoons). The blood samples will be used to analyze the changes in your blood sugar
over time in response to the glucose drink that we gave you.
• The study oral glucose tolerance test for patients in this research study: You prepare for
the test the same way. An extra 5mL (for a total of 15mL extra) will be withdrawn at the
same time points as above. The total blood withdrawn from your vein is approximately
35 mL (less than 3 tablespoons). The additional blood samples will be used to analyze
the changes in your lipids (fat) and blood insulin (a hormone that responds to blood
sugar) over time in response to the glucose drink that we gave you. This is not part of
standard care.
Because participants in the study need a different test than non-participants, we will need to
know if you are interested in participating before you complete your oral glucose tolerance test.
Rarely, the results of your oral glucose tolerance test may show that you have a medical
condition which means you cannot participate in the study. If this is the case, your physician
will inform you.
Questionnaires/Diaries
At your first visit at My Clinic, you will be asked to fill out a Weight and Health History
Questionnaire and the PARmed-X for Pregnancy. Completing these items is part of standard
care; your doctor will ask you to complete them whether you enroll in the study or not.
However, we will be using information from these questionnaires in the study.
If you agree to participate in this study, you will also be asked to complete a Physical Activity
Survey at your initial visit. This is not part of standard care. Once you have completed the
glucose tolerance test, you will be asked to complete a food diary for 3 consecutive days,
including one weekend day. You will also be given a pedometer and a log sheet to record the
number of daily steps you take.
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Group Assignment
Once you have completed these logs, you will be assigned at random, that is, by a method of
chance (like the flip of a coin), to one of the study groups. There are three study groups you may
be assigned to:
1. The first group (10 participants) will be assigned to receive the full Nutrition & Exercise
Lifestyle Intervention Program (NELIP) intervention. If you are assigned to this group,
you will be introduced to a walking program at London Health Sciences Centre –
Victoria Hospital, and will be encouraged to come to the hospital 3 to 4 times per week
for walks ranging from 25-40 minutes throughout your pregnancy. You will be given a
pedometer and log sheet in order to record your daily steps. You will also receive
information on the dietary program you will be following throughout your pregnancy.
2. The second group (10 participants) will be assigned to receive only the exercise
component of the NELIP intervention. If you are assigned to this group, you will be
introduced to the walking program and encouraged to come to LHSC for your walks, but
you will not receive any dietary intervention.
3. The third group (10 participants) will be assigned to receive only the nutrition
component of the NELIP intervention. You will not be involved in the walking
program, but you will receive information on the dietary program you will be following
throughout your pregnancy.
Alternatively, if you are not willing to be randomized to one of the three study groups, you can
choose to be in the control group. These 30 control participants will be assigned to receive
standard care; that is, they will not receive any of the NELIP intervention. However, we will still
need your consent to be a control participant, as we will still be taking additional blood samples,
having you complete additional questionnaires, and having you return to the clinic at 6 and 12
months post-partum.
Nutrition Program
If you are assigned to group 1 or group 3, you will receive the nutrition component of the
NELIP. After completing the 3-day food diary, you will receive instructions on our nutrition
program. The purpose of the controlled nutrition regime is to promote good eating habits, to
control excessive weight gain and to regulate your blood sugar levels. Once per week throughout
the program, you will be required to record for a 24-hour period everything you ate and drank
during that time period. This will assist us in adjusting your nutrition program as your pregnancy
progresses.
Controlled Walking Program
If you are assigned to group 1 or group 2, you will receive the exercise component of the NELIP,
which consists of a walking program in which you will walk for 25 minutes, 3 to 4 times per
week, adding 2 minutes each week, until 40 minutes is reached and then maintained until
delivery. You will be given a pedometer and log sheet to keep track of daily steps. You should
follow a walking pace that is easy for you to maintain without you becoming breathless. You
will have the option of either walking an indoor track at My Clinic with supervision by a study
volunteer, on a treadmill in your own gym, on an outdoor trail (weather permitting) or in your
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neighbourhood. We encourage you to come to the clinic for your walks.
Visits
If you agree to participate in this study as a program participant (groups 1-3), we will ask you to
come to My Clinic every Friday to track weekly weight gain.
At 28 Weeks of pregnancy
As part of your standard care, your doctor will request a second oral glucose tolerance test. As at
your initial test, if you choose to participate in this study, an additional 20mL of blood will be
drawn to assess changes in your lipids and blood insulin levels.
At 34 Weeks of pregnancy
As part of your standard care, your doctor will request a third oral glucose tolerance test. As at
your initial test, if you choose to participate in this study, an additional 20mL of blood will be
drawn to assess changes in your lipids and blood insulin levels.
You will also be asked to complete the Physical Activity Survey again. You are under no
obligation to complete this questionnaire, and you may refuse to answer any or all of the
questions.
Delivery
After you deliver, one of our research staff will visit you and your new baby within 6 to 18
hours. We will collect your baby’s length and birth weight and the weight of your placenta from
your hospital chart. We will measure head size, chest size and abdomen size of your baby, using
a cloth tape measure. We will record placental weight. We will record any complications which
may have occurred during delivery, and the APGAR scores. These are numbers that refer to your
baby’s colour, breathing and reflexes at 1 minute and 5 minutes after birth. Finally, we will
measure 6 skin fold sites on your baby. The sites that we will measure are: the front and back of
the arm, between the shoulder blades, the front of one thigh, the front of the belly by the bellybutton, and just above the hip bone. There are no known risks with this procedure.
Six Months Postpartum
At 6 months post delivery, we will ask you to return to the clinic for a follow-up visit. We will
ask you to complete the Breastfeeding and Infant Feeding Questionnaire and the Physical
Activity Survey. You are under no obligation to complete these questionnaires, and you may
refuse to answer any or all of the questions.
As previously described, we will measure your infant’s length, weight and head circumference,
chest circumference, abdomen circumference, hip circumference, arm circumference, mid-thigh
circumference and calf circumference. We will also measure 6 skinfold sites on your infant. The
front and back of the arm, between the shoulder blades, the front of the thigh, the front of the
belly by the belly-button and just above the hip bone. Infant circumferences will be taken using a
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soft cloth tape measure, and a special infant skinfold caliper will be used for the skinfold
measurements. There are no known risks with this procedure. You will be weighed and we will
also measure your waist (at the area of your belly-button) and hips (at the widest part of your
hips) using a soft cloth tape.
The total time for this visit will be one hour.
Twelve Months Postpartum
At 12 months post delivery, we will ask you to return to the clinic for a follow-up visit. We will
ask you to complete the Breastfeeding and Infant Feeding Questionnaire and the Physical
Activity Survey. You are under no obligation to complete these questionnaires, and you may
refuse to answer any or all of the questions.
As previously described, we will measure your infant’s length, weight and head circumference,
chest circumference, abdomen circumference, hip circumference, arm circumference, mid-thigh
circumference and calf circumference. We will also measure 6 skinfold sites on your infant. The
front and back of the arm, between the shoulder blades, the front of the thigh, the front of the
belly by the belly-button and just above the hip bone. Infant circumferences will be taken using a
soft cloth tape measure, and a special infant skinfold caliper will be used for the skinfold
measurements. There are no known risks with this procedure. You will be weighed and we will
also measure your waist (at the area of your belly-button) and hips (at the widest part of your
hips) using a soft cloth tape.
The total time for this visit will be one hour.
Risks and Benefits to You if You Participate in This Study
There are no known risks to your participation in this study. If you are randomized to
one of the groups receiving the exercise component and you have previously been
inactive, you may experience muscle cramps and fatigue when you begin the exercise
program.
Participation in this study may be of no direct benefit to you. The benefits to you and your
family may include prevention of excessive weight gain during pregnancy and minimizing
weight retention after the baby is born. You may also gain information about healthy eating and
how to be active for you and your family that will last you a lifetime.
Other Information You Need to Know About Taking Part in This Study
Participation in this study is voluntary. You may refuse to participate, refuse to answer any
questions, or withdraw from the study at any time with no effect on your future care. If you
withdraw from the study at any time, we may still use your data compiled up to that point.
If your medical condition changes throughout the course of the study, and your physician
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determines that continuation in the study would impair your health or that of your baby, you will
be advised at that time to discontinue the program. We will still include you in the study and you
will continue to receive ongoing medical care. If, during the course of this study, new
information becomes available that may relate to your willingness to continue to participate, this
information will be provided to you by the investigators.
An alternative to the procedures described above is not to participate in the study and
continue on just as you do now. There is no guarantee of a personal benefit by participating
in the study. Regardless of your decision to participate you would still receive continuing
medical care.
Biological Specimens
Any specimen(s) (e.g., blood) obtained for the purposes of this study will become the property of
the researchers/sponsors and once you have provided the specimens you will not have access to
them.
The specimen(s) will be discarded or destroyed once they have been used for the purposes
described in the protocol.
Compensation and Costs
Your participation in this research will not involve any additional costs to you or your health
care insurer, and you will not be compensated for your participation in the study. We will
arrange for you to park free of charge at Victoria Hospital for those visits that are required
only for this research study. For study visits that occur with your clinical care, your
parking will not be covered.
Specific Things You Should Know About Confidentiality
Your confidentiality will be respected. The information collected will be used for this current
research project only. Your records will be kept locked in a cabinet in a secure office. You will
be given a unique identification number and will not be personally identified in any way.
However, it is important to note that the original signed research consent form and the data
which will follow will be included in your health record. If the results of this study are published
or presented to groups of other researchers or health care professionals, they will be presented as
group data, and your name will not be associated with any specific result without your consent to
the disclosure.
We will strive to ensure the confidentiality of your research–related records. Absolute
confidentiality, however, cannot be guaranteed, as we may have to disclose certain
information under certain laws. Representatives of the University of Western Ontario Health
Sciences Research Ethics Board may require access to your study-related records or may
need to follow-up with you to monitor the conduct of this research.
While we will do our best to protect your information there is no guarantee that we will be able
to do so. The inclusion of your initials and your date of birth may allow someone to link the data
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and identify you.
Contact Information
If you have any questions about your rights as a research participant or the conduct of
the study you may contact Dr. David Hill, Scientific Director, Lawson Health Research
Institute, (519) 667-6649.
What You Need to Know About Signing the Consent Form
If during the course of this study new information becomes available that may relate to your
willingness to continue to participate, this information will be provided to you by the study
investigators.
You do not waive any legal rights by signing the consent form. You will be given a copy of
this letter of information and consent form once it is signed.
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Bringing an evidence-based Nutrition and Exercise Lifestyle Intervention Program
(NELIP) for obese pregnant women into clinical practice
Consent to Participate as a Control
I have read the letter of information, have had the nature of the study explained to me and I agree
for myself and my child to participate as controls. All questions have been answered to my
satisfaction.
While I do not wish to participate in this research study, I am willing to have my information
used as a control participant. This involves:
•
•
•

Having additional blood samples (15-20mL total) taken at oral glucose tolerance tests at
intake, 28 weeks, and 34 weeks;
Completing additional questionnaires not required for clinical care; and
Returning to the clinic at 6 and 12 months post-partum for study follow-up.

___________________________________
Control Participant Name (print)
___________________________________ _______________________
Control Participant Signature
Date
Person conducting the informed consent process including administration and explanation of the
form:
___________________________________
Printed name

________________________________
Date

__________________________
Signature
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Appendix A5 Consent to Participate

Bringing an evidence-based Nutrition and Exercise Lifestyle Intervention Program
(NELIP) for obese pregnant women into clinical practice
Consent to Participate
I have read the letter of information, have had the nature of the study explained to me and I agree
for myself and my child to participate. All questions have been answered to my satisfaction.

___________________________________
Participant Name (print)
___________________________________ _______________________
Participant Signature
Date
Person conducting the informed consent process including administration and explanation of the
form:
___________________________________
Printed name

________________________________
Date

__________________________
Signature
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Appendix A6 Three-Day Food Record
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Appendix A7 Seven-Day Pedometer Log
PEDOMETER/ACCELEROMETER LOG
NELIP STUDY – UNIVERSITY OF WESTERN ONTARIO
Unique ID #
Pedometer #
Accelerometer #
DAY 1
DAY 2
DAY 3
PUT ON PEDOMETER AS SOON AS YOU GET OUT OF BED & SET IT TO ZERO
Did you exercise? Y N
Did you exercise? Y N
Did you exercise? Y N
IF YES: Steps Before:
IF YES: Steps Before:
IF YES: Steps Before:
_______________
_______________
_______________
Steps After:
Steps After:
Steps After:
_______________
_______________
_______________
ONCE IN BED, RECORD
ONCE IN BED, RECORD
ONCE IN BED, RECORD
Total Steps:
Total Steps:
Total Steps:
DAY 4
DAY 5
DAY 6
Day 7
PUT ON PEDOMETER AS SOON AS YOU GET OUT OF BED & SET IT TO ZERO
Did you exercise? Y
Did you exercise? Y Did you exercise? Y Did you exercise? Y
N
N
N
N
IF YES:
IF YES:
IF YES:
IF YES:
Steps Before:
Steps Before:
Steps Before:
Steps Before:
_____________
_____________
_____________
_____________
Steps After:
Steps After:
Steps After:
Steps After:
_____________
_____________
_____________
_____________
ONCE IN BED,
ONCE IN BED,
ONCE IN BED,
ONCE IN BED,
RECORD
RECORD
RECORD
RECORD
Total Steps:
Total Steps:
Total Steps:
Total Steps:
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Appendix A8 NELIP Meal Plan

NELIP Suggested Meal Plan
FOOD GROUP

DINNER

PM
SNACK

LUNCH

AM
SNACK

BREAKFAST

TIME

Starch Foods

EVENING
SNACK
BED
SNACK
FBBT 2009

1

Protein Foods

1

Milk
Extra
Vegetables

2
recommended

Starch Foods

1

Fats & Oils
Vegetable &
Fruit

1

Starch Foods

2

Protein Foods

3

Fats & Oils

2

Milk

1

Extra
Vegetables

recommended

Starch Foods

1

Vegetable &
Fruit
Fats & Oils

1

1
1

Starch Foods

2

Fats & Oils

2

Vegetable &
Fruit

1

Protein Foods

3

Milk
Extra
Vegetables

Water

CHOICES

1
recommended

Starch Foods
Fats & Oils

1
1

Protein Foods

1

Vegetable &
Fruit

1

Starch Foods

1

Milk

2

ONE DAY SAMPLE MENU

ALTERNATIVES

Target = ~25 grams of carbohydrates
½ cup cereal (e.g. Shreddies) or ½ small multigrain bagel
or 1 slice whole wheat bread
1 egg or 1 ounce (~30 grams) low-fat cheese
or 1 Tbsp (15 mL) peanut butter
1 cup (250 mL) skim milk or ¼ cup (60 g) low-fat fruit yogurt
2 slices tomato or ½ cup mushrooms & green pepper (in
omelette)
Target = ~25 grams of carbohydrates
½ whole wheat English muffin or 1 small oat bran muffin or
5 multigrain crackers
1 tsp (5 mL) soft (e.g. Becel) margarine
1 cup vegetable juice or ½ medium apple or 1 small orange
or 2 apricots
Target = ~35 grams of carbohydrates
2 slices whole wheat or pumpernickel bread or 1 cup legumes
3 ounces lean meat or skinless poultry
e.g. 90 g or 1 medium roasted chicken breast
1 tsp olive oil and ¼ avocado or 2 tsp regular salad dressing
½ cup (125 mL) skim milk or ½ cup (125 mL) plain fortified soy
beverage
1 slice tomato and 1 cup spinach salad (with avocado and oil
above) or 2-3 slices cucumber and a celery stick or
½ cup sliced sweet peppers
Target = ~25 grams of carbohydrates
5 whole wheat crackers or 4 melba toasts or 1 slice flax bread or
½ small multigrain bagel or 1/3 cup legumes
½ cup mixed raw vegetables or ½ cup grapes or 1 kiwi
or 4 tsp raisins (small box) or ½ small banana
10 peanuts or 5 cashews or 1 Tbsp (15 mL) cream cheese
Target = ~45 grams of carbohydrates
or baked beans or 1 cup pasta or 1 cup (250 mL)
potato or corn or couscous
2 tsp (10 mL) oil or soft, non-hydrogenated margarine or 2 Tbsp
(30 mL) low-fat sour cream
½ cup (125 mL) cooked carrots or peas or mixed vegetables
3 ounces lean meat or poultry or fish; or ½ cup legumes
e.g. 90 g roast beef or a medium pork chop
½ cup (125 mL) skim milk or plain fortified soy beverage
½ cup (125 mL) tossed salad or ½ cup (125 mL) broccoli or
½ cup (125 mL) cauliflower or ½ cup (125 mL) green beans
Target = ~25 grams of carbohydrates
½ whole wheat pita or 3 cups (750 mL) plain popcorn
1 Tbsp (15 mL) low-fat mayo or 1 tsp (5 mL) margarine
¼ cup (60 mL) canned salmon or tuna or low-fat cottage cheese
or 1 egg or 1 Tbsp (15 mL) peanut butter
8 baby carrots or 1 cup celery or 1 peach or 1 kiwi or 1 small
orange or ½ pear or ½ cup berries
Target = ~25 grams of carbohydrates
1 fig Newton cookie or ¾ cup plain cheerios or ½ cup oat flakes
or 2 rice cakes
¾ cup (175 g) low-fat plain yogurt or 1 cup (250 mL) skim milk or
1 cup (250 mL) plain fortified soy beverage

May substitute with 1
cup of low-fat plain
chocolate, strawberry,
or vanilla ice cream.
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